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To determine whether membrane-related events may be involved in 
attenuated luteal function after gonadotropin-releasing hormone (GnRH) 
administration, corpora lutea (CL) were removed from 10 beef heifers on day 7 
of the estrous cycle after i.v. injection of GnRH or saline on day 2 of the cycle. 
Luteal slices were incubated with saline (control), luteinizing hormone (LH) or 
8-bromo-cAMP for 2 h. In vivo administration of GnRH reduced LH and cAMP-
stimulated progesterone production by tissue (p<0.01), but basal progesterone 
production was not affected (p>0.05). Luteal adenylyl cyclase activity did not 
differ between saline and GnRH-treated animals (p>0.05). Results of this 
experiment suggested that GnRH-induced alteration of bovine luteal function 
may be due to an effect distal to the point of cAMP accumulation. 
To explore further the effect of GnRH on luteal cell function, 10 heifers 
were injected with saline or GnRH and CL removed as above. Dissociated 
(mixed) and small luteal cells (SC) were cultured overnight, then incubated for 2 
h with medium alone (control), LH or cAMP. In vitro treatment with LH and 
cAMP increased progesterone in the medium relative to controls (p<0.01), 
Redacted for Privacyhowever, there was no effect of GnRH injection on progesterone production 
(p>0.05) nor in the percentage of large cells (LC) present in the mixed cell 
cultures (p=0.95). It has been previously found that the ratio of LC to SC 
increases in GnRH-treated animals. Many LC can be ruptured during 
dissociation of the CL, and it is possible that this procedure altered the number 
of LC, such that any differences that may have existed between the saline and 
GnRH-exposed CL were minimized. These data suggest that differences in the 
LC to SC ratio may indeed account for attenuated luteal function after exposure 
to GnRH. 
To examine if early administration of GnRH alters response of the CL to 
prostaglandin (PG) Fav beef heifers were injected with saline or GnRH on day 2 
of the cycle (n=4/group), then injected with PGF2, on day 8 and the CL 
removed 60 min later. Blood samples were collected for oxytocin (OT) analysis 
at frequent intervals after PGF2c, injection and for progesterone at 0 and 60 min. 
Induction of the early response gene c-jun or release of OT by PGF2c, was not 
altered by GnRH injection (p>0.05). Injection of PGF2c, decreased serum 
progesterone by 60 min post-injection (p<0.05), but was also unaffected by 
GnRH (p>0.05). These data support the hypotheses that c-jun expression and OT 
release are involved in PGF2einduced luteolysis, but early administration of 
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FUNCTION IN RESPONSE TO EXOGENOUS GONADOTROPIN-
RELEASING HORMONE 
REVIEW OF THE LITERATURE 
OVERVIEW OF THE ESTROUS CYCLE IN DOMESTIC ANIMALS 
The estrous cycle in domestic female animals is characterized by several 
phases. The most obvious is the period of behavioral estrus, in which the female 
is sexually receptive to the male. Hormonally, this time is characterized by high 
systemic concentrations of estrogen, originating in the preovulatory follicle. 
Follicle-stimulating hormone (FSH) as well as luteinizing hormone (LH) from 
the anterior pituitary drive the synthesis of estradiol by the follicular cells. This 
ovarian estrogen also forms a positive feedback loop with LH, to eventually 
induce a spike release of LH that causes ovulation. In the cow, behavioral estrus 
lasts for only 12 to 24 h, with ovulation occurring approximately 12 h after the 
end of estrus. The cells of the ovulated follicle transform themselves into a 
endocrine structure known as the corpus luteum (CL). The stage of metestrus 
occurs during this short time of corpus luteum development. The luteal phase, 
which is comprised of metestrus and diestrus, is the dominant phase of the cycle, 
lasting 16 to 17 days of the 21 day cycle in the cow and sow. The luteal phase is 
also the dominant portion of the 16 to 17 day estrous cycle of the ewe and the 19 
to 25 day cycle of the mare. During diestrus, the corpus luteum is fully 
developed and secretes increased quantities of progesterone to help establish 
and maintain early pregnancy if the ovum has been fertilized. If the animal is 
not pregnant, regression of the corpus luteum occurs and progesterone secretion 2 
declines. Growing follicles can attain larger size and release more estrogen once 
progesterone levels decrease. Thus the period of follicular dominance, the 
follicular or proestrus phase, begins. Behavioral estrus follows this proestrus 
period. Ovulation occurs around the time of estrus. Ewes ovulate 24 to 30 h 
after the beginning of estrus, sows 35 to 45 h after the onset of estrus, mares 
approximately one to two days before the end of estrus and, as mentioned, cows 
10 to 12 h after the end of estrus (Hafez, 1987). 
While the cow has estrous cycles throughout the year, and only becomes 
acyclic in response to stressors such as extreme heat, some animals have 
naturally occurring periods of anestrus. Ewes and mares are known as "seasonal 
breeders" who cycle in the fall and spring, respectively. Thus ewes are called 
"short-day" breeders and mares are "long-day" breeders. Photoperiod is the 
critical regulator of this phenomenon. The sow can breed throughout the year, 
but goes through a period of lactational anestrus after giving birth. 
HYPOTHALAMO-HYPOPHYSIAL AXIS 
Hypothalamic and Pituitary Hormones 
The hypothalamus and pituitary are perhaps the most important 
regulators of endocrine function in the body, and as such they control many 
essential and non-essential bodily systems, including reproductive functions. 
The hypothalamus lies below the thalamus and forms the walls and lower part 
of the third ventricle of the brain. It is the source of several peptide hormones 
that stimulate or inhibit the secretion of hormones from the anterior pituitary. 
For example, thyrotropin-releasing hormone, a three amino acid peptide, 3 
stimulates the release of thyrotropin, or thyroid-stimulating hormone (TSH). 
The decapeptide gonadotropin-releasing hormone (GnRH) causes the secretion 
of LH and FSH from gonadotrope cells of the pituitary. Corticotropin-releasing 
hormone is responsible for stimulating the release of corticotropin 
(adrenocorticotropic hormone or ACTH). Somatocrinin is somatotropin (growth 
hormone)-releasing hormone. There is also some evidence for prolactin and 
melanocyte-stimulating hormone (MSH)-releasing factors. Hypothalamic 
hormones that inhibit pituitary hormone secretion also exist, such as 
somatostatin (somatotropin release-inhibiting factor), prolactin-inhibiting factor 
(most likely dopamine) and MSH release-inhibiting factor (Hadley, 1992). 
The pituitary, also known as the hypophysis, is composed of two main 
parts or lobes, the adenohypophysis or anterior pituitary, and the 
neurohypophysis, or posterior pituitary. In many species, an intermediate lobe, 
considered part of the adenohypophysis also exists. The anterior pituitary is the 
site of production of several major hormones. Somatotropin and prolactin are 
single subunit proteins that possess numerous amino acid sequences in common 
and are members of the growth hormone family of proteins. They are also 
structurally related to placental lactogen, a hormone produced by the placenta of 
species such as human, rat, mice and sheep (Miller and Eberhardt, 1983; Slater et 
al., 1986). Somatotropin stimulates general somatic cell growth (Greep, 1974), 
including enhancement of amino acid incorporation into muscle protein and 
stimulation of extracellular collagen deposition (Isaksson et al., 1985; Hughes 
and Friesen, 1986). The effects of somatotropin can be due to direct action or can 
work through other chemical factors ("somatomedins") such as insulin-like 
growth factors. Prolactin, as its name implies, partly regulates mammary  
growth, development and lactation, although it has many other diverse  
functions (Jaffe, 1981).  4 
The gonadotropins, LH and FSH, as well as TSH, are glycoproteins 
composed of two subunits, a and 0. Within a species, the a subunit of the three 
hormones is identical, while the 0 subunit confers biological specificity (Boothby 
et al., 1981). The gonadotropins play important roles in control of reproduction, 
and their functions will be discussed further throughout this literature review. 
The target of action for TSH is the thyroid gland, which produces the metabolic 
regulatory hormones thyroxine and triiodothyronine. These hormones can 
influence many bodily functions. They are also considered "permissive" because 
they are required for the actions of other hormones in some cases. For example, 
their presence is needed with that of somatotropin for early growth and 
development (Green ,1987; Hays, 1988). 
Other pituitary hormones are derived from the peptide precursor pro-
opiomelanocortin (POMC). Within its structure are the amino acid sequences for 
ACTH and a-MSH. These sequences are similar, in fact a-MSH is comprised of 
the first 13 amino acids of ACTH; thus each hormone can stimulate the target 
tissues of the other. The major role of the 39 amino acid long ACTH is to 
stimulate steroidogenesis of glucocorticoids by the adrenal gland. 
Corticosteroids are important in intermediary metabolism and other body 
functions. The major source of a-MSH is actually the intermediate lobe. Several 
other products are also derived from POMC including y-MSH, 0-lipotropin and 
0-endorphin (Hadley, 1992). 
Oxytocin and vasopressin are two hormones of the neurohypophysis. In 
actuality, these peptides are produced in neurons of the hypothalamus, and 
transported down the axons of these cells for storage in the posterior pituitary. 
Oxytocin, a nine amino acid long peptide, controls milk release from the 
mammary glands and contractions of the uterus, and may be important in 
maternal and sexual behaviors (Soloff et al., 1979; Pedersen and Prange, 1985, 5 
Murphey et al., 1987). It is also found in the ovary where it has other functions. 
Vasopressin, also known as antidiuretic hormone, is important in water balance 
(Robertson et al., 1976). 
Feedback Systems 
"It used to be said that the anterior pituitary is the conductor of the 
endocrine orchestra; if that is so, then it is the hypothalamus that writes the 
score, in response to feedback from the audience." -F.J. Karsch 
Feedback is a critical element of all biochemical systems. Both the 
hypothalamus and pituitary are important regulators of endocrine events in the 
body. However, they must communicate with each other as well as with target 
organs to function effectively. There are two direct routes of communication 
between the hypothalamus and pituitary. The hypothalamus and posterior 
pituitary are connected neurally, while the hypothalamo-hypophysial portal 
system is a vascular connection between the hypothalamus and the anterior 
pituitary. The first evidence for a "downward" flow in the portal vessels (from 
the hypothalamus to the pituitary) was provided by Wislocki and King (1936), 
and has subsequently been observed directly in a number of species (Everett, 
1994). However, several researchers have shown that some retrograde flow may 
occur (Oliver et al., 1977; Page and Bergland, 1977; Bergland and Page, 1978). 
Whatever the mechanism, pituitary hormones do modulate secretion of their 
own releasing factors by "short-loop" feedback on the hypothalamus. Target 
organs affect the function of the pituitary and hypothalamus by "long-loop" 
feedback: their hormone products travel through the blood stream to affect 
secretion of stimulatory hormones from the hypothalamus and pituitary. While 6 
both negative and positive feedback mechanisms exist, to respectively inhibit or 
further stimulate hormone production, negative feedback is much more common 
in biological systems (Hadley, 1992). 
Regulation of GnRH Secretion 
The structure and function of purified mammalian gonadotropin-
releasing hormone has been known for almost 25 years (Schally et al., 1971). It 
was isolated from hypothalamic nuclei and structurally identified as a 
decapeptide with the amino acid sequence (pyro)Glutamate-Histidine-
Tryptophan-Serine-Tyrosine-Glycine-Leucine-Arginine-Proline-Glycine-NH2. 
As mentioned above, release of this hormone can be affected by several feedback 
mechanisms. A great deal of GnRH secretion is ultimately controlled via long-
loop feedback by gonadal steroids, such as progesterone and estradiol. In 
general, progesterone is inhibitory to GnRH secretion, while estradiol is 
stimulatory. This fits in with the overview of the estrous cycle, in that estradiol 
positively feeds back on the hypothalamus and pituitary to allow increasing 
amounts of LH to be released so it can cause ovulation. During the luteal phase, 
only small pulses of LH, and thus GnRH, are needed to maintain the corpus 
luteum. While these steroids can act directly on GnRH neurons (Kordon and 
Drouva, 1990), they also modulate the actions of nearby neurons that release 
products that affect GnRH secretion (Kordon et al., 1994). For example, 
noradrenergic neurons are steroid-sensitive (Heritage et al., 1977), and their 
product, norepinephrine, can stimulate GnRH neurons to release GnRH. 
Neurons that produce neuropeptide Y (NPY) act in a similar manner. Estrogen 
has been shown to enhance the sensitivity of GnRH neurons to NPY and 7 
norepinephrine, while progesterone treatment after estrogen-priming has not 
been found to affect the pulsatile release of these neuromodulators (Terasawa, 
1994). Gamma aminobutyric acid and opioid neurons, on the other hand, are 
inhibitory to GnRH release but are also modulated by steroids (Flugge et al., 
1986; Nikolarakis et al., 1986). Their products can act by inhibiting the 
noradrenergic and NPY neurons, and may also directly inhibit GnRH neurons 
(Leranth et a1.,1985). 
Role of GnRH in LH Secretion 
Pulsatile secretion of GnRH is necessary for maintaining different aspects 
of gonadotrope secretory function, including regulation of GnRH receptors on 
the cells, expression of gonadotropin subunit genes, maintenance of cellular LH 
pools and release of the gonadotropins themselves (Belchetz et al., 1978; Clayton, 
1982; Barkan et al., 1985; Haisenleder et al., 1991). For example, GnRH has been 
shown to increase mRNA for the 13 subunit of LH in vitro (Andrews et al., 1988). 
However, changes in GnRH pulse amplitude and frequency can have 
differential effects on up- and down-regulation of gonadotropin gene 
expression, and thus subsequent production and availability for secretion 
(Haisenleder et al., 1994). 
As noted, the gonadotrope cells of the pituitary contain plasma membrane 
receptors for GnRH. Binding of GnRH to its receptor causes a cascade of events 
to occur, including Ca2+ mobilization and activation of protein kinase C (PKC), 
that ultimately induces the secretion of gonadotropins (Conn, 1994). One way 
that the effects of GnRH on these cells may be modulated is through changes in 
the number of pituitary GnRH receptors on their cell surfaces. During the 8 
estrous cycle in several species, including rats, hamsters, ewes and cows, the 
maximum number of GnRH receptors is found just before the preovulatory LH 
surge (Clayton et al., 1980; Adams and Spies, 1981; Crowder and Nett, 1984; Nett 
et al., 1987). After the LH surge, the number of GnRH receptors decreases 
rapidly. The number of receptors present during pregnancy and lactation are 
also less than what is observed during the estrous cycle (Clayton et al., 1980; 
Marian et al., 1981). However, receptor number does not necessarily directly 
correlate to amount of LH released in response to GnRH (Young et al., 1985). 
For example, maximal LH secretion in vitro is found when receptors are only 
20% saturated. Additionally, ewes can still fully respond to GnRH 
administration when 50% of the receptors are blocked with a GnRH antagonist 
(Wise et al., 1984). Whether this notion of "spare receptors" holds true for other 
functions of the gonadotrope (e.g., FSH release) is unknown (Conn, 1994). 
THE FOLLICULAR PHASE 
Stages of the Follicle 
The mammalian ovary is a dynamic organ with changes to its structure 
occurring daily. Most of these changes are due to the growth and atresia of 
follicles. Unlike males, who produce sperm throughout their lives, females 
possess their entire supply of primordial follicles either before birth (primates, 
ruminants) or neonatally (rodents, rabbits; Fortune, 1994). Oocytes are stored 
within individual follicles through the development of the female to maturity. 
The stages of follicular development can be classified by several criteria, 
including oocyte morphology and size or the number of supporting granulosa 9 
cells and their organization (Gore-Langton and Armstrong, 1994). All follicles 
begin as primordial or primary follicles. Primary follicles consist of a oocyte, 
arrested in prophase I of meiosis, surrounded by a single layer of flattened 
granulosa cells. These are the follicles that make up the resting pool of follicles 
in the ovary and are not under hormonal control. During the reproductively 
active years, follicles leave the resting pool gradually and continually and begin 
to grow. The signals that initiate this break from the resting phase, and the 
mechanisms to ensure gradual departure are unknown (Fortune, 1994). 
Secondary follicles are characterized by addition of granulosa cells by mitosis, 
with at least two layers of granulosa cells present, as well as increases in oocyte 
size. The zona pellucida, a glycoprotein matrix surrounding the oocyte, and the 
basal lamina, separating the granulosa cells from the rest of the ovary, are also 
evident. Tertiary (antral, Graafian) follicles are those that feature an antrum 
filled with follicular fluid with further increases in granulosa cell number. 
Thecal cells are also present outside of the basement membrane. Large antral 
follicles can be classified as nonovulatory or preovulatory to indicate their 
maturity (Gore-Langton and Armstrong, 1994). 
In some species, such as rat, primate and pig, follicles of ovulatory size 
(dominant follicles) develop only during the follicular phase and thus are 
destined for ovulation. For example, ultrasonography during the human 
menstrual cycle has revealed that ovulatory-size follicles do not develop during 
the luteal phase, but that a group of growing follicles emerges during the early 
follicular phase and one of those follicles continues to grow through the late 
follicular phase (Pache et al., 1990). In the pig it also appears that follicles of 
ovulatory size do not develop during the luteal phase. On day 3, no follicles are 
larger than 4 mm, while on day 13 the largest are 3 to 6 mm. By day 16 of the 
cycle (late luteal phase), average follicle diameter is 4.8 mm and only one of six 10 
gilts studied possessed large (6 to 9 mm) follicles. Ovulatory follicles are 7 to 11 
mm at estrus (Par low et a1.,1964; Clark et al., 1982; Guthrie and Knudsen, 1984). 
During pregnancy or pseudopregnancy in the rat, follicles do not grow to 
ovulatory size until the last two to three days preceding the next estrus 
(Hirshfield, 1991). 
In other species such as cattle and horses, recruitment, follicular selection, 
and dominance occur at regular intervals during the estrous cycle. However, 
only the dominant follicles present during the follicular phase ovulate. As 
mentioned above, why some follicles are recruited to develop and fewer still are 
selected for dominance is still unknown, although a slight rise in plasma 
concentration of FSH seems to precede follicular recruitment (Fortune, 1994). 
For example, in primates, basal concentrations of FSH are slightly higher at the 
beginning of the follicular phase in comparison to the late follicular phase or the 
luteal phase (Abraham et al., 1972; Goodman et al., 1977). In rats, a secondary 
surge of FSH on the day of estrus is closely followed by the recruitment of the 
next set of ovulatory follicles (Smith et al., 1975). In the cow, the secondary 
surge of FSH on the day of ovulation also precedes the first follicular wave of the 
estrous cycle (Dobson, 1978; Walters and Schallenberger, 1984), and small rises 
in FSH occur before the second and third follicular waves as well (Adams et al., 
1992). Additionally, ablation (in rats) or delay (in cows) of follicular recruitment 
after ovulation occurred when injected follicular fluid (containing inhibin) 
blocked the secondary FSH surge on the day of estrus (Grady et al., 1982; 
Turzillo and Fortune, 1990). 
Ultrasonography has provided a useful tool for physically studying the 
recruitment and growth of follicles during the estrous cycle in species such as 
the cow. Until recently, patterns of follicular development in cattle were 
deduced indirectly by cyclical changes in hormone profiles and by a variety of 11 
experimental methods, such as inspection of the ovaries at slaughter, 
laparoscopic examination after dye marking and analysis of follicular fluid after 
destruction of follicles of selected sizes (reviewed by Fortune et al., 1988). Sirois 
and Fortune (1988) utilized ultrasonography to analyze patterns of follicular 
growth and regression throughout entire estrous cycles in cattle. They found 
that development of bovine follicles occurs in distinct, regular patterns. Heifers 
exhibited development of two or three follicular waves during an estrous cycle, 
with the three-wave pattern more commonly observed. A "wave" consists of 
emergence of a group of follicles  5 mm in diameter. Within several days, one 
follicle becomes larger than the rest and is considered the dominant follicle. In 
cycles with the three-wave pattern, waves began on days 2, 9 and 16 of the cycle, 
whereas in animals exhibiting a two-wave pattern they emerged on days 2 and 
11. In animals with three follicular waves the average cycle length was 20.7 
days. Thus the ovulatory follicle first emerged approximately 6 days prior to 
ovulation. Other laboratories have found similar results in patterns of follicular 
waves (Savio et al., 1988; Ginther et al., 1989), although Ginther et al. (1989) 
reported that the two-wave pattern was more prevalent and the three-wave 
pattern was the alternative. Basal concentrations of progesterone and 
gonadotropins, and length of the estrous cycle appear to be important in 
regulating the wave-like pattern of follicular development found in cattle (Sirois 
and Fortune, 1990; Fortune, 1993; Stock and Fortune, 1993). 
Concentrations of progesterone also appear to regulate size and 
distribution of follicles in the ewe (Brand and de Jong, 1973; Dailey et al., 1982), 
possibly acting via LH release (Schrick et al., 1993). Unlike the cow, however, 
transrectal ultrasonography of developing follicles during the estrous cycle and 
early pregnancy in ewes has revealed that follicles are recruited to the 
gonadotropin-dependent pool in a continuous manner, rather than in a wave-12 
like pattern (Schrick et al., 1993). Follicular development did show two "peaks" 
of activity, both during periods of low progesterone (during the first 8 days of 
the cycle and during luteal regression). However, no dominant follicles were 
present during these peaks. The absence of a single dominant follicle allows for 
the presence of several follicles capable of ovulating, a necessity in this 
polyovular species. 
Hormones Produced by the Follicle 
Two-Cell Theory of Estradiol Synthesis 
The steroid hormone estradiol is a primary product of the ovarian 
follicles. Estradiol is a necessary product because it is responsible for events 
such as estrous behavior and positive feedback with the hypothalamus and 
pituitary to release LH, which eventually causes ovulation. In species including 
cattle, sheep, pigs and rats, interaction between the two cell types of the follicle, 
the theca and granulosa cells, is necessary for estrogen biosynthesis. This theory 
was first formed by Falck (1959). In the "two-cell, two-gonadotropin" model, LH 
acts on the theca interna to stimulate the production of androgens from 
cholesterol. The enzyme 17a-hydroxylase/C17-20 lyase catalyzes the rate-
limiting conversion of 17a-hydroxyprogesterone to androstendione in the theca 
cells. Granulosa cells do not express this enzyme and thus are incapable of 
androgen biosynthesis. However, androgens (androstendione and also 
testosterone) do diffuse across the basement membrane to the granulosa cells 
from the theca interna. Under the influence of FSH, granulosa cells aromatize 13 
the androgen to estrogen. The aromatizing capacity of the preovulatory follicle 
almost completely resides within the granulosa cells (Hillier, 1994). 
Oxytocin 
Another important hormone produced by the follicle is oxytocin. 
Oxytocin was identified in preovulatory follicles of cows by Wathes et al. (1984) 
and Schams et al. (1985) and in ewes by Wathes et al. (1986). Aladin-
Chandrasekher and Fortune (1990) found that oxytocin stimulated progesterone 
secretion from bovine granulosa cells shortly before the ovulatory LH surge, 
thus suggesting that oxytocin might be involved in regulating the follicular to 
luteal phase shift, from estradiol production to progesterone production. Voss 
and Fortune (1991) then examined oxytocin production from cells of 
preovulatory bovine follicles collected both before and after the endogenous 
LH/FSH surge. Oxytocin production by granulosa cells isolated before the 
LH/FSH surge was increased by the addition of LH or FSH to the cell culture 
medium. The predominant source of oxytocin is the granulosa cells because the 
theca produced little oxytocin when cultured alone, and the source of the 
oxytocin that was detected was considered to be contaminating granulosa cells. 
Oxytocin production by granulosa cells collected after the preovulatory LH/FSH 
surge was not altered by addition of gonadotropins, but the quantity of oxytocin 
produced was much greater than from those cells collected before the LH/FSH 
surge. This increase in oxytocin may be mediated by an increase in 
oxytocin/neurophysin-I mRNA in granulosa cells that occurs after the LH/FSH 
surge (Voss and Fortune, 1992). Voss and Fortune (1993) have also shown that 
estradiol has a biphasic effect on oxytocin secretion from follicular cells. 
Oxytocin production by granulosa cells was inhibited with high doses of 14 
estradiol, but stimulated by low doses. These results are consistent with the 
results of Voss and Fortune (1991), in that oxytocin production by granulosa cells 
is lower before the endogenous LH/FSH surge, when concentrations of estradiol 
in follicular fluid are high (Fortune and Hansel, 1985; Fortune et al., 1988), and 
increased after the surge, when estradiol in follicular fluid is low. Thus the 
pattern of oxytocin secretion by the granulosa cells throughout the follicular 
phase suggests a role for oxytocin in regulation of luteinization and/or 
ovulatory events. 
Ovulation 
Ovulation involves a complex set of processes, that will be discussed 
briefly here, and has been described as an inflammatory reaction (Espey, 1980). 
It encompasses not only follicular rupture and release of the ovum, but also the 
events leading up to this biological "volcanic eruption" (Hill et al., 1935). The 
ovulatory process is initiated when the follicular tissue is stimulated by a surge 
of pituitary gonadotropins. Both LH and FSH have been recognized as being 
important in ovulation (Nalbandov et al., 1973), and under normal conditions 
they probably act together to initiate ovulation (Espey and Lipner, 1994). 
However, under experimental conditions, LH (Hisaw, 1947), hCG (McFarland, et 
al., 1989) or FSH alone (Schenken et al., 1984; Armstrong and Opaysky, 1988) can 
induce ovulation. But ovulation only occurs in mature follicles that contain 
adequate concentrations of LH receptors (Richards and Hedin, 1988; McFarland 
et al., 1989; Leung and Steele, 1992). Steroid synthesis by the follicle is increased 
after exposure to LH. Progesterone synthesis seems especially important in 
ovulation. For example, a progesterone synthesis inhibitor, isoxazol, was shown 15 
to block ovulation in the ewe (Murdoch et al., 1986). The progesterone receptor 
antagonist RU 486 also partially blocked ovulation in rats that were treated with 
hCG to cause ovulation (Tsafriri et al., 1987). 
Ovarian steroids and LH seem to synergize in stimulating follicular 
plasminogen activator (PA) secretion. Plasminogen activator is known to 
increase in preovulatory follicles (Beers, 1975; Beers and Strickland, 1978), and 
plasmin itself, the product of PA action on plasminogen, can decrease the tensile 
strength of the preovulatory follicle wall (Beers, 1975). It is thought plasmin acts 
by activating collagenase to initiate proteolytic processes that end with follicular 
rupture (Beers and Strickland, 1978). Prostaglandins may also be important 
players in the ovulatory process. Inhibition of prostaglandin synthesis by 
treatment with indomethacin, a cyclooxygenase inhibitor and nonsteroidal anti-
inflammatory agent, has been shown to prevent ovulation in a number of 
species, including rodents, sheep, pigs and cows (Armstrong and Grinwich, 
1972; O'Grady et al., 1972; Ainsworth et al., 1979; Downs and Longo, 1982; 
De Silvia and Reeves, 1985; Murdoch and McCormick, 1991). The preovulatory 
LH/FSH surge causes a local increase in prostaglandin (PG) Fa, and PGE2. 
However, the actual role for these prostanoids in ovulation is not clear, as some 
studies have indicated that they are involved in proteolytic enzyme activation 
(PA and/or collagenase), while others have found they have little effect 
(Murdoch et al., 1986; Murdoch and McCormick, 1991; Reich et al., 1991). 
The preovulatory surge of gonadotropins ends because the pituitary 
becomes refractive to GnRH (Chakraborty et al., 1974; Kesner and Convey, 1982), 
not because of depletion of gonadotropins in the pituitary (Convey et al., 1981). 
Timing of ovulation varies among species. Ovulation occurs in ewes 24 to 30 h 
after the beginning of estrus, in sows 35 to 45 h after the onset of estrus, in mares 16 
approximately one to two days before the end of estrus and in cows 10 to 12 h 
after the end of estrus (Hafez, 1987). 
THE LUTEAL PHASE 
Luteinization 
Luteinization encompasses a series of events that morphologically and 
biochemically transform the cells of the ovulated follicle into the endocrine 
structure known as the corpus luteum. While this process truly begins before 
follicular rupture (Espey and Lipner, 1994), the actual breakdown of the 
basement membrane of the follicle allows blood vessels from the theca interna to 
invade the cavity of the ruptured follicle. This neovascularization is a process 
unique to the corpus luteum because it is the only place in the body in which 
angiogenesis occurs without unwanted tissue damage as the precipitating event. 
Within 48 h, the previously avascular granulosa cell layer has developed a 
complex network of new blood vessels (Koos, 1989). Some angiogenic factor 
secreted by the cells is thought to be responsible for the blood vessel formation. 
One potential candidate is basic fibroblast growth factor, which is produced by 
bovine granulosa cells (Neufeld et al., 1987) and corpus luteum (Gospodarowicz 
et al., 1985). Basic fibroblast growth factor derived from the CL has been shown 
to be angiogenic in a bioassay using vascularization of chick embryo 
choriallantoic membranes (Gospodarowicz et al., 1985).  However, other growth 
or hormone factors may also be involved in neovascularization of the CL (Koos, 
1989). At this early stage of development, the tissue is known as the corpus 
hemorrhagicum, indicative of the amount of blood vessels present. During this 17 
stage there is also significant hypertrophy and hyperplasia of theca cells (O'Shea 
et al., 1980). 
As luteinization progresses, the theca cells migrate into the follicular 
cavity and become dispersed among the luteinizing granulosa cells. Within a 
few hours of ovulation, granulosa cells accumulate smooth endoplasmic 
reticulum, containing 313-hydroxysteroid dehydrogenase activity, and rounded 
mitochondria, characteristics of steroid secreting cells. These changes correlate 
with the initial rise in circulating progesterone (Niswender and Nett, 1994). 
Additionally, in response to the preovulatory surge of LH, cytochrome P450 side 
chain cleavage (SCC) enzyme activity increases, with an associated decrease in 
17a-hydroxylase P450 activity (Rodgers et al., 1986, 1987; Lauber et al., 1991). 
These changes allow increased formation of pregnenolone from cholesterol, with 
subsequent creation of progesterone as the final product. Corpora lutea of some 
species, such as primates, do retain the ability to produce estradiol, although the 
follicular to luteal transition does entail a temporary decline in estrogen 
production compared to that of the preovulatory follicle (Hillier, 1994). 
Changes in the populations of cell-surface gonadotropin receptors also 
occur during luteinization.  Receptors for FSH disappear from granulosa-
derived cells following ovulation, most likely due to internalization of receptor-
hormone complexes and reduced gene expression (Nakamura et al., 1991). 
However, FSH receptors have been found on CL from cows (Manus et al., 1984) 
and hamsters (Oxberry and Greenwald, 1982). After the preovulatory LH surge, 
LH receptors are down-regulated, again probably due to internalization and 
reduced gene expression (Segaloff et al., 1990; LaPolt et a1.,1990; Nakamura et 
al., 1991). However, expression of these receptors is subsequently enhanced 
approximately 48 h after exposure to gonadotropin (Braden et al., 1994). 18 
Growth of the corpus luteum occurs quickly during its development. In 
the bovine, the CL rapidly increases in weight and progesterone content from 
days 3 to 12 of the cycle; these characteristics then remain relatively constant 
until day 16, when regression begins. In the ewe and the sow, both progesterone 
content and weight of the CL increase rapidly from days 2 to 8 and remain 
constant until day 15, when regression commences (Erb et al., 1971). 
Corpus Luteum Structure and Function 
Large and Small Luteal Cells 
At least two distinct luteal cell types are found in the corpus luteum of 
many species such as cow (Ursely and Leymarie, 1979 ; Koos and Hansel, 1981), 
sow (Corner, 1919; Lemon and Loir, 1977), ewe (O'Shea et al., 1979), dog (Abel et 
al., 1975), rhesus monkey (Gulyas et al., 1979), human (Crisp et a1.,1970) and rat 
(Wilkinson et a1.,1976). Koos and Hansel (1981) first examined the morphology 
of large and small cells of the mid-cycle (days 11 to 13) bovine corpus luteum by 
transmission electron microscopy. They found that large luteal cells (?_ 25 um) 
contained a central, round nucleus with dispersed chromatin and a distinct 
nucleolus, two types of mitochondria, extensive rough endoplasmic reticulum, a 
highly convoluted cell surface and small (0.3 um) electron-dense granules. 
These small granules were later identified to contain neurophysin (Fields and 
Fields, 1986) and oxytocin (Fields and Fields, 1986; Fields et al., 1992). The 
number of secretory granules has been shown to change during the estrous 
cycle, with the highest percentage of large cells containing secretory granules on 
day 7 (84%) and day 11 (64%), while lower percentages of large cells contained 19 
granules on days 3 (3%), 17 (16%) and 19 (8%; Fields et al., 1992). Small luteal 
cells are described as having acentric, deeply-indented cup-shaped nuclei with 
heterochromatin lining the nuclear envelope, a relatively smooth surface, 
predominantly smooth endoplasmic reticulum, polymorphic mitochondria, and 
a large Golgi complex (Koos and Hansel, 1981). These authors noted that when 
cells were dispersed and clumps of small cells were observed, they appeared 
held together by extensively interdigitated microvilli. 
Small and large luteal cells differ in ways that directly contribute to their 
functional capabilities. For example, the profile of hormone receptors found on 
their cell surfaces differ. Small ovine luteal cells have been shown to contain 
only low-affinity (nonspecific) binding sites for PGF2a, while large luteal cells 
contain a single class of high affinity binding sites with a Kd of 17.4±2.3 nM 
(Balapure et al., 1989). Fitz et al. (1982) reported that on a per cell basis, large 
luteal cells from superovulated ewes bound approximately 30 times more PGF2a 
and ten times more PGE2 than small luteal cells. This group also found that 
small luteal cells contained significantly more receptors per cell for LH/human 
chorionic gonadotropin (hCG) than did large cells. Other groups, however, have 
reported that in normally cycling ewes (Harrison et al., 1987), cows (Chegini et 
al., 1991) and rats (Nelson et a1.,1992) the number of LH receptors on the two 
cell types was similar. However, the functionality of LH receptors on large cells 
is questionable, because in vitro exposure of large cells to LH does not cause an 
increase in cAMP or progesterone secretion as observed with small cells (Hoyer 
and Niswender, 1986). Still, prostaglandin Fla and LH have been implicated in 
luteal regression and maintenance, respectively, thus understanding which 
hormone binds each cell type can aid in elucidation of specific large and small 
cell functions. 20 
Origin of Luteal Cells 
Because the follicle, from which the corpus luteum is derived, is 
composed of two distinct steroidogenic cell types, theca and granulosa cells, it is 
not surprising that two steroidogenic cell types exist in the corpus luteum. The 
percentages of cell types that comprise the corpus luteum and the origin of these 
cells, however, have come under some debate. Several histological studies on 
the formation of the bovine CL suggested that luteal cells are derived from both 
types of cells in the follicle, with the large luteal cells arising from the granulosa 
cells and the small luteal cells arising from the theca interna (McNutt, 1924; 
Foley and Greenstein, 1958; Gier and Marion, 1961; Donaldson and Hansel, 
1965). However, it has also been suggested that in the ewe and the cow some 
large cells are derived from small luteal cells (Warbritton, 1934; Donaldson and 
Hansel, 1965; Fitz et al., 1982). 
Alila and Hansel (1984) used monoclonal antibodies specific to granulosa 
and theca cell surface antigens to determine the contribution of the follicular 
cells to the bovine corpus luteum. They found that the granulosa cell antibody 
bound the large luteal cells, but percentage binding decreased as the corpus 
luteum aged. For example, percentage of large cells binding the granulosa 
antibody was 77±6% on days 4 to 6, 47.5±3% on days 10 to 12, and 30±3% on 
days 16-18. Binding to large cells from corpora lutea of pregnancy declined even 
further and was undetectable after 100 days gestation. Of the small luteal cells, 
14% bound the granulosa cell antibody on days 4 to 6 of the cycle, and no 
binding was detected thereafter. The authors noted that these small cells 
resembled large cells in both nuclear and cytoplasmic features (Koos and 
Hansel, 1981) and suggested that these granulosa-derived small cells had not yet 
enlarged. However, most of the small cells bound the theca cell antibody 21 
throughout the estrous cycle: binding was 70±4, 69±3 and 58±6% on days 4 to 6, 
10 to 12 and 16 to 18, respectively. Binding of theca antibody to small cells was 
present in CL from pregnant cows, but binding did decline as gestation 
advanced. Binding of large luteal cells to the theca antibody actually increased 
during the estrous cycle. On days 4 to 6, 10±1.3% of large cells bound the 
antibody, while on days 10 to 12 the percentage binding increased to 46±3%. 
These investigators concluded that large luteal cells are initially derived from 
granulosa cells of the follicle, while small luteal cells are of thecal origin, but 
during the luteal life span small luteal cells differentiate into large luteal cells. It 
should be noted that some criticism of this study has been made (O'Shea et al., 
1989) because enzymatically dispersed luteal cells were used for analysis, and 
losses of some of the large granulosa-derived cells could have occurred during 
this process (see below). 
Composition of the Corpus Luteum 
When using enzymatic dispersion techniques large cells generally do not 
account for more than 10% of the total luteal cell population (i.e.,  large 
luteal cells, ?_ 90% small luteal cells) at any given time during the estrous cycle, 
including mid-cycle (Hansel et al., 1987, 1991). Small to large cell ratios of 20:1 
to 40:1 (Hansel et al., 1987) and 10.2:1 (Weber et al., 1987) have been reported. 
However, it is recognized that cell numbers based on dispersion techniques are 
generally lower than morphometric techniques, because losses due to dispersion 
and separation of cells by size probably occur (Rodgers et al., 1984; O'Shea et al., 
1989; Hansel et al., 1991). O'Shea et al. (1989) examined the numbers and types 
of cells in the bovine CL during the cycle by histological evaluation. They 22 
determined, on a volume basis, that large luteal cells comprise a large part of the 
day 12 CL (40±7%), followed by small luteal cells (28±3%), endothelial cells and 
pericytes (13±2%), intercellular space (9.5±3%), fibrocytes (6±5%), other cell 
types/unidentifiable cells (2±0.6%) and vessel lumen space (1.2±0.4%). On a per 
cell basis, however, endothelial cells and pericytes, with a spherical cell diameter 
of approximately 11 1..tm, were found to be in the majority (52%), followed by 
small luteal cells (27%). Fibrocytes accounted for 10% of the cells, 
other/unidentified for 7.5%, while large luteal cells only comprised 3.5% of the 
total cells present. Thus, the small cell to large cell ratio in this study was 7.6:1. 
This study has come under some scrutiny (Hansel et al., 1991) because the 
animals were subjected to two doses of the luteolytic hormone PGF2a, which is a 
treatment known to reduce fertility (Smith et al., 1984) and alter luteal cell 
number and CL function (Hansen et al., 1987). 
Lei et al. (1991), however, obtained somewhat similar results for 
percentages of luteal and nonluteal cells using animals that had been 
synchronized using a progesterone intrauterine device and one PGF2a injection. 
They stated that fertility of these animals has been shown to be equal to that of 
normally cycling animals. In addition to mid-cycle corpora lutea, they examined 
CL from the early and late luteal phases as well as corpora albicantia and CL 
from pregnant animals. They found that more large cells were present during 
the late luteal phase (61% of total luteal cells) than at earlier times in the cycle (44 
to 45% of total luteal cells). Thus the idea that small luteal cells develop into 
large luteal cells is somewhat supported. In mid-cycle corpora lutea, on a per 
cell basis, 60% of the cells were nonluteal cells and 40% were luteal cells. Of the 
luteal cells, 56% were small cells and 44% were large cells. In this case, then, the 
percentage of large cells out of the total number of cells would be higher 
(approximately 18%) than the 3.5% reported by O'Shea et al. (1989) and the small 23 
cell to large cell ratio at mid-cycle would be 2.6:1. However, Lei et al. (1991) 
used a different size cutoff for distinguishing between large and small luteal 
cells than most others, as they considered a cell to be a large cell if it was _19.5 g 
m. Generally, however, large cells are considered to be __22 or 23 gm and small 
cells approximately 15 to 22 gm. Thus differences in cell size interpretation 
might account for differences in percentage large cells reported, although their 
mean cell sizes did fall within the normally accepted ranges. 
Parry et al. (1980) did not mention the use of PGF2a, for their study in 
which they used slaughterhouse CL from cows of known days of the cycle. 
Their morphometric results appear similar to those of O'Shea et al. (1989) as 
well, because on day 13 of the cycle the CL, on an area basis, consisted of 71% 
luteal cells, 7.3% blood vessels, 17.4% extracellular space and 4.3% other tissue. 
However, while these data seem comparable to those presented above on a 
volume basis, Parry et al. (1980) did not distinguish between large and small 
luteal cells in this instance. They did note that the large cells contained many 
electron dense granules as others have also reported. 
Non-steroidogenic Cells in the Corpus Luteum 
As noted above, the corpus luteum contains several types of non-
steroidogenic, nonluteal cells. These cells may play roles in luteal function. 
Macrophages have been reported to be present in the CL of several species 
including rat (Bulmer, 1964), human (Gillim et al., 1969, Lei et al., 1991), mouse, 
(Kirsch et al., 1981) rabbit (Bagavandoss et al., 1988) and cow (Lobel and Levy, 
1968). Macrophages are phagocytic cells and have been shown to contain 
remnants of luteal cells in degenerating CL (Paavola, 1979), although through 
their secretory abilities they have also been shown to potentially be both 24 
luteotropic and luteolytic.  Kirsch et al. (1981) reported that co-culture with 
macrophages promoted progesterone secretion by mouse luteal cells. The luteal 
cells did not respond to macrophage-conditioned media, implying that physical 
proximity of the two cell types was important for the observed stimulation. A 
role in luteolysis has been suggested as most likely, however, as few 
macrophages were found several days after ovulation, while many were found 
in regressing CL (Bagavandoss et al., 1988).  These researchers found that 
macrophages are a likely source of tumor necrosis factor a in the CL. This 
cytokine could act through receptors found on numerous endothelial cells in the 
CL to aid in regression of this gland (Azmi and O'Shea, 1984; Bagavandoss et al., 
1988). 
Another type of white blood cell, the lymphocyte, is also present in the 
corpus luteum and is capable of secreting cytokines. Additionally, they may 
play a direct cytotoxic role and(or) recruit macrophages to the CL (Bagavandoss 
et al., 1988). Emi et al. (1991) suggested a luteotropic role for lymphocytes in the 
human corpus luteum. They found that progesterone production by granulosa 
cells luteinized in vitro increased when they were cultured in combination with 
lymphocytes or with lymphocyte-conditioned media. They determined that 
some secreted protein product of high molecular weight was responsible for this 
increase in steroidogenesis, and that its action was synergistic to that of 
gonadotropins. This group did not find a significant stimulatory effect of 
macrophages on the cells. 
Other vascular elements, such as endothelial cells, are present in large 
numbers in the CL, due to the extensive neovascularization that occurs during 
luteal development. Endothelial cells are known to secrete PGI2, (MacIntyre et 
al., 1978), which has been shown to have a luteotropic effect on mixed bovine 
luteal cells (Milvae and Hansel, 1980). Girsh et al. (1995) proposed that 25 
endothelial cells may be able to establish intercellular contacts with large and 
small bovine luteal-like cells (granulosa and theca cells luteinized in vitro) in 
culture. Endothelial cells stimulated progesterone production from large cells, 
possibly via the action of PGI2, suggesting a role for endothelial cells in 
maintenance of the CL. However, endothelial cells also produce and secrete the 
peptide endothelin (Yanagisawa et al., 1988), which has an inhibitory effect on 
steroidogenesis (Hison et al., 1991; Iwai et al., 1991) and luteinization (Iwai et al., 
1991). Girsh et al. (1995) did postulate that endothelial cells may play a 
luteolytic role, because depression of hormone-stimulated progesterone secretion 
by PGF2a, found with intact luteal slices, was not observed with isolated small 
or large luteal-like cells. However, in co-cultures of large luteal cells with 
endothelial cells, PGF2a significantly inhibited forskolin-stimulated 
progesterone production. Thus it is possible that endothelial cells, or some 
factor produced by them, could contribute to the effects of PGF2a on luteal 
function. 
Control of Progesterone Production 
The steroid hormone progesterone is the considered to be the most 
important product of the corpus luteum, because without it pregnancy could not 
be established or maintained. It is also considered an important factor in 
maintaining function of the CL itself. Production of progesterone also seems to 
be differentially regulated in small and large luteal cells, and many factors can 
influence progesterone production both in vivo and in vitro. However, during 
the estrous cycle, secretion of progesterone and maintenance of the corpus 
luteum are ultimately dependent on LH in most species, including the cow, ewe 
and mare. Exceptions include laboratory animals, such as rats, which also rely 26 
on prolactin as a luteotropic support (Niswender et al., 1985), the sow, which 
requires both LH and estrogen (Gardner et al., 1963; Cook et al., 1967) and the 
rabbit corpus luteum, which is dependent on estradiol (Braden et al., 1994). 
Luteinizing hormone-stimulated progesterorie production and the cAMP cascade 
As mentioned previously, large luteal cells contain few LH receptors and 
therefore it is not surprising that large cells do not respond with greatly 
enhanced progesterone synthesis when incubated with LH. Ursely and 
Leymarie (1979) reported that bovine large cells could respond to LH with 
increased progesterone production; however, about 1000 times more LH was 
need in the large cell cultures to attain the same level of stimulation as with the 
small cells. Koos and Hansel (1981) found that bovine large luteal cells produce 
20 times more progesterone than small luteal cells without the addition of LH. 
However, with LH, progesterone production by small cells increased 
dramatically (11-fold increase in 1 h, sixfold increase in 3 h), while large luteal 
cells only showed a twofold increase in progesterone production. Weber et al. 
(1987) found that prior to any incubation, progesterone content in bovine large 
luteal cells was seven times higher than in small luteal cells and 13 times higher 
after 3 h incubation. They also found that large cells did not respond to LH in 
culture with enhanced progesterone synthesis. 
Fitz et al. (1982) studied how ovine luteal cells responded to the addition 
of LH. In their experiments, large cells produced about 20 times more 
progesterone than an equal number of small cells in the absence of hormonal 
stimulation. However, with the addition of LH or dibutyryl cAMP (dbcAMP), 
small cell progesterone production increased greatly, while the response of the 
large cells was only 10% that of the small cells. Thus large luteal cells produce 27 
greater basal amounts of progesterone and may actually secrete the majority of 
progesterone produced by the CL of domestic animals. For example, some 
speculate that in the ewe, at least, the large cells are responsible for 80% of 
progesterone produced by the CL (Niswender et al., 1985). 
In contrast to domestic animals, regulation of progesterone in large and 
small cells of the rat seems to be somewhat different. In one study, both large 
and small luteal cells from pregnant rats responded to dibutyryl cAMP with 
increased progesterone production; however, the large cells were responsive to a 
10-fold lower dosage than the small cells (Smith and Sridaran, 1989). Also, large 
cells responded to increased substrate availability (25-hydroxycholesterol) with 
an increase in progesterone production. Thus the authors of this study 
suggested that large luteal cells are an important source of progesterone in the 
rat. However, Nelson et al. (1992) found that large and small cells from corpora 
lutea of pregnant rats were equally sensitive to LH stimulation of progesterone 
production. 
Although they appear to be responsible for much of the progesterone 
production by the CL, mechanisms by which the large luteal cells of domestic 
animals produce this steroid are not well understood. The progesterone 
contribution of the small cells cannot be discounted, however, and they may be 
quite important in normal corpus luteum function including progesterone 
production, especially considering that LH is the primary luteotropic agent in 
domestic animals. In addition, how LH acts on the small luteal cell, which 
contains many LH receptors, to increase steroidogenesis is fairly well 
understood. 
Luteinizing hormone exerts its influence by binding to its receptor on the 
cell surface. The LH/hCG receptor is a single polypeptide about 674 amino 
acids long. It is a member of the G protein-coupled receptor superfamily, and 28 
contains seven hydrophobic transmembrane regions. The third cytoplasmic loop 
interacts with the stimulatory GTP-binding protein, Gs. The a subunit of this G 
protein can activate the membrane-bound enzyme adenylyl cyclase, which 
causes the conversion of ATP to cAMP in the cytoplasm. Cyclic AMP is an 
important "second messenger" molecule; it is the intracellular signal by which 
the action of LH is carried out (Leers-Sucheta and Stormshak, 1991). Cyclic AMP 
may have several important actions in the luteal cell. Primarily, it activates 
cAMP-dependent protein kinase A (PKA) by causing dissociation of the 
regulatory and catalytic subunits of the enzyme. This enzyme can then 
phosphorylate proteins such as cholesterol esterase, which frees cholesterol from 
intracellular stores. It may also be involved in activation of proteins that 
transport cholesterol into the mitochondria (Niswender and Nett, 1994). 
Free cholesterol is transported into the inner membrane of the 
mitochondria, where it is acted upon by the cytochrome P450 side-chain 
cleavage (SCC) enzyme complex. The side-chain cleavage reaction is considered 
to be the rate-limiting step in steroidogenesis. However, it is actually the 
mobilization and transport of cholesterol to the enzyme, and not the catalytic 
action of the enzyme itself, that controls steroid synthesis (Waterman, 1995). 
Until recently, it was only known that some "labile protein factor" was required 
for cholesterol transport into the inner mitochondrial membrane. One recently 
identified candidate for the transport of cholesterol is steroidogenic acute 
regulatory protein (StAR), which has been cloned and expressed in MA-10 
mouse Leydig tumor cells and has been shown to support steroidogenesis in the 
absence of hormonal stimulation (Clark et al., 1994). This protein does appear to 
be required for normal adrenal and gonadal steroidogenesis, although the exact 
mechanism by which it acts is not yet known (Lin et al., 1995). Immunocyto-
chemical localization of this protein has shown that its expression is induced in 29 
mitochondria of 30 to 40% of rat granulosa cells in culture after exposure to FSH 
for 24 h, with greater than 90% of cells positively staining after 48 h. The StAR 
protein expression was increased in the vast majority of MA-10 cells' 
mitochondria after 6 to 8 h treatment with 8-bromo-cAMP (Stocco et al., 1995) In 
the rabbit, presence of this mitochondrial protein in the corpus luteum appears 
to be regulated by estradiol, which is luteotropic in rabbits, and generally 
correlated with plasma concentrations of progesterone (Keyes et al., 1995). Once 
cholesterol is transported into the mitochondria of the luteal cell, cytochrome 
P450 SCC cleaves it to pregnenolone, which is subsequently transported out of 
the mitochondria and to the smooth endoplasmic reticulum. There, 
pregnenolone is converted to progesterone by the action of 313-hydroxysteroid 
dehydrogenase/A5-44 isomerase, and the progesterone can be secreted from the 
luteal cell (Niswender and Nett, 1994). 
Cyclic AMP may have other actions in luteal cells beyond its involvement 
in progesterone production. For example, it seems to be necessary for the 
formation of luteal cells from granulosa cells (Richards et al., 1979) and allows 
for the maintenance of luteal cell morphology in cell cultures (Gospodarowicz 
and Gospodarowicz, 1975). Additionally, cAMP may be the intracellular 
messenger involved in the differentiation of small luteal cells into large luteal 
cells (Niswender et al., 1985). 
Importance of lipoproteins 
The substrate for progesterone synthesis in luteal cells, as noted, is 
cholesterol. Three main sources exist from which the luteal cell may obtain this 
precursor. The primary source is considered to be low-density lipoproteins and 30 
high-density lipoproteins produced by the liver and carried in the circulation. 
Luteal cells contain receptors for these molecules, which allow them to bind to 
the cells. The lipoprotein-receptor complex is internalized and combined with 
lysosomes and the cholesterol is liberated. This free cholesterol can be stored in 
the cell as cholesterol esters in lipid droplets, which are then the secondary 
source of cholesterol for steroid biosynthesis by the cell. Additionally, luteal 
cells can make cholesterol within the cell directly from acetate, although this 
only occurs under certain conditions and is not preferred (Niswender and Nett, 
1994). 
The importance of lipoproteins in progesterone synthesis has been 
documented by several in vitro studies. Pate and Condon (1983) investigated the 
effects of both serum and isolated high- and low density lipoproteins (HDL, 
LDL) on mid-cycle bovine luteal cells cultured for 11 days. On all days of 
culture 10% serum inhibited LH-stimulated progesterone production by the cells 
and was found to be inhibitory at a point prior to the accumulation of cAMP, 
because cells in both serum-free and serum-supplemented media were able to 
respond to dbcAMP with increased production of progesterone. However, the 
actual mechanism for the inhibition of LH-stimulated progesterone production 
in serum-supplemented cultures is not known. Additionally, both dbcAMP-
stimulated and basal progesterone production by cells in serum-supplemented 
media were greater than those of cells cultured under serum-free conditions. 
The authors postulated that these latter findings could be due to the presence of 
lipoproteins in serum, thus providing a potential substrate for steroidogenesis. 
To test this, they cultured bovine luteal cells with freshly isolated lipoproteins. 
During the first 24 to 72 h of culture LDL did not increase progesterone 
synthesis, but HDL stimulated a 1.5-fold increase over controls. In addition, 
neither HDL nor LDL inhibited LH-stimulated progesterone production. When 31 
cells were not exposed to lipoproteins until day 3 of culture, addition of HDL 
and LDL for 2 to 4 more days greatly increased progesterone production without 
affecting LH response. This study showed that isolated serum lipoproteins can 
be a source of cholesterol substrate for progesterone synthesis by bovine luteal 
cells in culture. O'Shaughriessy and Wathes (1985) also found this to be the case, 
although they did not culture cells under serum-free conditions: bovine luteal 
cells were incubated in the presence of 10% whole serum, lipoprotein deficient 
serum (LPDS) or LPDS plus HDL or LDL. Both HDL and LDL in 10% LPDS 
medium increased basal and dbcAMP stimulated progesterone production. In 
this case the cells were more sensitive to LDL, although maximal response to the 
different lipoproteins did not differ. In vivo, HDL may actually be more 
important, since it is the major lipoprotein class present in bovine serum (Jonas, 
1972; Raphael et al., 1973). Addition of HDL with a high cholesterol to protein 
ratio was found to stimulate progesterone production by bovine luteal cells more 
than supplementation with HDL having a low cholesterol to protein ratio 
(Carroll et al., 1992), again indicating that increased cholesterol substrate 
availability aids in progesterone synthesis with lipoprotein supplementation. 
Other factors affecting progesterone production 
There exist many other chemical factors that can modulate progesterone 
production by luteal cells both in vivo and in vitro. These include growth factors, 
cytokines and other locally produced hormones. There are probably many other 
factors that have yet to be discovered. However, many exist whose effects on 
progesterone production have been elucidated, and some of them will be 
discussed here. 32 
In utilizing in vitro cell culture, care must be taken when exposing luteal 
cells to chemical agents not normally found in vivo. As shown above, addition of 
serum, often used in cell culture, can be detrimental to response of luteal cells to 
LH. Also, serum contains many unknown and varied amounts of hormones that 
can otherwise affect growth and(or) function of luteal cells in culture. However, 
serum-free medium does not seem to contain all the factors necessary for proper 
luteal cell function in culture. Addition of insulin or an insulin-transferrin-
selenium (ITS) supplement to bovine luteal cells in serum-free culture has been 
shown to be essential for LH-stimulated progesterone production and aids in 
maintenance of basal progesterone synthesis (Poff et al., 1988). Commonly used 
antibiotics, such as gentamicin and penicillin-streptomycin do not seem to affect 
luteal cell function in culture, however, amphotericin-B, an antifungal agent, has 
been shown to decrease LH-stimulated progesterone production, although it did 
not affect basal progesterone production (Poff et al., 1988). Another common 
additive to cell culture medium is phenol red, a pH indicator. However, this 
compound has estrogenic activity, and its use is best avoided when culturing 
steroidogenic or steroid-responsive cells. 
Of course, there are many factors found in the local chemical milieu of the 
CL in vivo that can affect its function. For example, the catecholamines 
dopamine and norepinephrine have been shown to be present in bovine luteal 
tissue on days 10 to 12 of the estrous cycle in ng/g quantities (Battista et al., 
1989). Studies have also shown that catecholamines can stimulate progesterone 
production from the bovine CL both in vivo and in vitro (Auletta et al., 1972; 
Condon and Black, 1976; Battista and Condon, 1986; Battista et al., 1987, 1989; 
Kotwica et al., 1991). Additionally, it was shown that epinephrine-, 
norepinephrine-, isoproterenol- (a (3-adrenergic receptor agonist; Condon and 
Black, 1976) or dopamine-stimulated (Battista et al., 1989) progesterone 33 
production was inhibited by propranolol, a 13-adrenergic receptor antagonist. At 
least dopamine-stimulated progesterone was not affected by an a-adrenergic 
receptor antagonist nor a dopamine-receptor antagonist (Battista et al., 1989). 
Thus it appears that stimulation of progesterone production by catecholamines is 
regulated through the 13-adrenergic receptor. Norjavaara et al. (1989) showed 
that in rat CL the 132 receptor subtype is found throughout pseudopregnancy, 
regardless of luteal age. In rabbit and pig, the 131 receptor subtype seems to 
dominate. The exact mechanism through which 13-receptor agonists exert their 
effects on progesterone production is still not clear, however. For example, there 
is no direct evidence that enzymes necessary for catecholamine production exist 
in the CL. Kotwica et al. (1991) found increases in plasma progesterone with 
infusion of a 13-adrenomimetic drug, bamethan sulfate, and suggested, based on 
the work of Hsueh et al. (1983), that catecholamines can regulate steroidogenic 
enzymes in the CL. They also suggested that innervation of CL may be an 
important source of catecholamines. 
Some growth factors, such as insulin-like growth factor, have also been 
implicated as having paracrine roles in the corpus luteum. Insulin-like growth 
factor-1 has been shown to increase progesterone secretion from luteal cells of 
the cow, rat and rabbit (McArdle and Holtorf, 1989; Dowd et al., 1990; 
Constantino et al., 1991; Talavera and Menon, 1991). Insulin itself has also been 
shown to increase progesterone release from the bovine CL (McArdle and 
Holtorf, 1989). Prostaglandins can be luteotropic; both PGE2 and PGI2 have been 
shown to increase progesterone from cow and sheep CL (Fitz et al., 1984; Ali la et 
al., 1988). Oxytocin has also been implicated in maintenance of the corpus 
luteum. Miyamoto and Schams (1991) found that in microdialyzed bovine CL 
oxytocin stimulated an acute and dose-dependent release of progesterone. 
Additionally, infusion of an oxytocin antagonist blocked the oxytocin-34 
stimulated, but not LH-stimulated, progesterone production. In early and mid-
cycle CL, pre-exposure to oxytocin increased LH-stimulated progesterone 
release, although when administered concomitantly no synergism between 
oxytocin and LH was evident. Stimulatory effects of oxytocin on progesterone 
production have also been shown with microdialyzed porcine CL Garry et al., 
1990) 
Luteolysis 
The primary function of the corpus luteum is to aid in establishment and 
maintenance of pregnancy. If the ovum is not fertilized, however, it is important 
that progesterone production ceases and the CL regresses in a reasonable period 
of time so a new estrous cycle, and thus another chance for pregnancy, can occur. 
Luteolysis is a complex process that involves both functional and structural 
regression of the CL. Many factors, well-defined or still undiscovered, are 
involved in luteal regression, but it is generally agreed that prostaglandin Fax is 
the hormone responsible for initiation of this process. 
Roles of Prostaglandin F2c, and Oxytocin 
In order for it to initiate luteolysis, PGF2a of uterine origin must first 
make its way to the corpus luteum. It is thought that a counter-current 
mechanism exists by which PGF2a in the uterine vein can cross into the ovarian 
artery. This vasculature is highly convoluted with the ovarian artery in close 
apposition to the uterine vein. McCracken et al. (1972) showed that during 
infusion of [3H]PGF2a into the uterine vein of ewes, labeled hormone could be 35 
detected in the ovarian artery, with amounts increasing as the infusion 
progressed. Only a small amount of radioactive PGF2a could be detected in the 
in the systemic blood, thus indicating that transfer from the uterine vein to the 
ovarian artery had occurred. In ewes greater than 99% of injected PGF2a is 
metabolized in a single pass through the lungs, so the need for such a 
mechanism is evident. However, in the cow Davis et al. (1984) showed that 
35.0±2.3% of injected [3H]PGF2a survived one passage through the lungs and 
15.7±6.9% remained after three passages. Thus it is possible that PGF2a also has 
a systemic effect in the cow. 
Once it reaches the corpus luteum, PGF2a can bind to its receptor on the 
large luteal cell (Fitz et al., 1983; Balapure et al., 1989). This receptor is coupled 
to the Gq protein, which interacts with a membrane-bound enzyme, 
phospholipase C (PLC; Smrcka et al., 1991). Phospholipase C can hydrolyze the 
membrane phospholipid phosphatidylinositol 4,5-bisphosphate, generating 
inositol trisphosphate (IP3) and diacylglycerol (DAG; Leung et al., 1986; Davis et 
al., 1987). These compounds are considered second messengers in the 
PLC/protein kinase C (PKC) system. Diacylglycerol remains in the membrane 
where it can activate PKC, while IP3 travels through the cytoplasm to the 
endoplasmic reticulum, where it causes the release of intracellular Ca2÷. 
Calcium can further activate PKC as well as other enzyme systems within the 
cell. Increased intracellular Ca2+ appears to mediate cytotoxic effects of PGF2a 
in luteal cells, possibly by an apoptotic mechanism (Sawyer et a1.,1990). Actions 
of PKC are thought to be ultimately responsible for the release of oxytocin from 
the large luteal cell. Activators of PKC have been shown to stimulate secretion 
of oxytocin from bovine luteal slices in vitro (Cosola-Smith et al., 1990) and 
membrane PKC activity has been correlated with plasma concentrations of 
oxytocin in vivo (Orwig et al., 1994). In the CL, PKC may act through 36 
phosphorylation of the myristoylated alanine-rich C-kinase substrate (MARCKS; 
Orwig and Stormshak, 1994; Stormshak et al., 1995), a protein which is known to 
be involved in secretory events in other cells ( Dunkley et al., 1986; Dunk ley and 
Robinson, 1986). 
Wathes and Swann (1982) first proposed that oxytocin could be found in 
the corpus luteum of ewes and cows. Subsequently, luteal concentrations of 
oxytocin have been found to be low in the early estrous cycle, maximal during 
mid-cycle and again low towards the end of the cycle (Sheldrick and Flint, 1983; 
Schams et al., 1985; Abdelgadir et al., 1987). Prostaglandin F2a, can cause the 
release of oxytocin, stored within secretory vesicles in large luteal cells (Fields 
and Fields, 1986; Theodosis et al., 1986), both in vivo (Schallenberger et al., 1984; 
Walters et al., 1984; Lamsa et al., 1989; Flint et al., 1990) and in vitro (Abdelgadir 
et al., 1987; Chegini and Rao, 1987; Jarry et al, 1992; Miyamoto et al., 1993). Thus 
it appears that PGF2a is a primary regulator of luteal oxytocin secretion. At the 
end of the estrous cycle, both oxytocin and PGF2a are secreted in an intermittent 
and concurrent pulsatile manner (Flint and Sheldrick, 1983; Walters et al., 1984). 
McCracken and Schramm (1983) proposed that a positive feedback loop exists 
between luteal oxytocin and uterine PGF2a to promote luteolysis. However, 
factors that initiate and terminate this loop have not been determined, although 
the primary candidate is release of oxytocin from the posterior pituitary (Silvia 
et al., 1991). 
Additional Contributors to Luteolysis 
Of course, PGF2a and oxytocin are not the only factors involved in 
regression of the corpus luteum. Initially, large luteal cells probably do respond 
to the luteolytic signal of PGF2a, but as mentioned previously, intercellular 37 
communication between large and small luteal cells, as well as between luteal 
and nonluteal cells, is probably important for luteal regression to proceed. 
These include cells of the immune system, which may be actively involved in 
luteolysis (Pate, 1994).  Increased numbers of eosinophils have been observed in 
CL of sheep that had been treated with PGF2c, (Murdoch, 1987). It has been 
suggested that the eosinophils might release cytotoxins that could injure luteal 
cells, cause changes in the cell membrane and(or) activate degradation of 
mRNA, resulting in luteal demise (Murdoch et al., 1988). Lymphocytes infiltrate 
the bovine CL starting on day 14 of the cycle (Lobel and Levy, 1968), before the 
onset of luteolysis. These cells produce lymphokines that attract and activate 
macrophages. Macrophages produce chemical products which may be involved 
in aiding luteal regression, such as tumor necrosis factor-a and interleukin-1 
(Adashi et al., 1994). For example, interleukin-113 slightly suppresses 
progesterone production and dramatically increases prostaglandin synthesis by 
bovine luteal cells (Nothnick and Pate, 1990).  Interestingly, structural luteolysis 
occurs less rapidly postpartum than at the end of the estrous cycle, and 
macrophages do not appear until day 15 postpartum (O'Shea and Wright, 1985). 
Some cytokine-induced luteolytic events may be mediated by the 
formation of reactive oxygen species (Riley and Behrman, 1991). Reactive 
oxygen species and lipid peroxides are produced by the ovary, such as during 
the synthesis of prostaglandins (Behrman and Romero, 1991). The production of 
hydrogen peroxide, which evokes antigonadotropic and antisteroidogenic 
actions in ovarian cells, is stimulated by PGF26, (Chance, 1979; Fridovich 1988; 
Lippman, 1989). Biological membranes are subject to attack by these oxidants 
because they contain high proportions of unesterified polyunsaturated fatty 
acids, which are especially sensitive to oxidative reactions. Orwig et al. (1992) 
suggested that the luteolytic effect of metabolites of the fatty acid 38 
eicosapentaenoic acid that was tested in ewes may be mediated by production of 
reactive oxygen species, as at least one of the metabolites tested has been found 
to be a weak stimulator of superoxide anion production. 
Maternal Recognition of Pregnancy 
Maternal recognition of pregnancy is the critical time when an embryo 
must signal its presence to the mother in order to block regression of the corpus 
luteum and allow pregnancy to continue (Short, 1969). Maternal recognition of 
pregnancy occurs at days 16 to 17 in cows and days 12 to 13 in ewes (Niswender 
and Nett, 1994) and days 15 to 17 in female goats (Gnatek et al., 1989). This time 
corresponds with the period of blastocyst elongation. The principal signals for 
maternal recognition of pregnancy in these ruminant species have been 
identified as proteins released by the trophoectoderm (Roberts et al., 1990). 
These conceptus proteins have been characterized and structurally identified as 
members of the interferon (IFN) all subclass (Imakawa and Roberts, 1989). 
Interferons are small proteins with antiviral and antiproliferative activities, and 
the conceptus proteins have been shown to have these activities (Roberts, 1989). 
The proteins were previously known as ovine trophoblast protein-1 (oTP-1), 
bovine trophoblast protein-1 (bTP-1; Imakawa and Roberts, 1989) and caprine 
trophoblast protein-1 complex (cTP-1 complex; Gnatek et al., 1989), although the 
current designation is as species-specific [Mr. 
Intrauterine administration of bTP-1 from days 15 to 21 in nonpregnant 
cows extended the interestrous interval from 19.5 to 26 days (Thatcher et al., 
1989a). Similar experiments in cows and ewes using bovine recombinant (br) 
IFNai also extended the time of progesterone production (Stewart et al., 1989; 39 
Thatcher et al., 1989a). Intramuscular injections of brIFNai from days 12 to 16 
after mating resulted in a decrease in estimated early embryonic loss from 24% 
in control ewes to 8% in treated ewes (Nephew et al., 1990). Thus recombinant 
interferons may actually be of use to the animal industry to prevent early 
embryonic loss. 
The mechanisms of action of trophoblast proteins are still under 
investigation. A specific receptor for oIFNt exists in the ovine endometrium and 
binding increases protein synthesis in the endometrium. However, oIFN., is not 
directly luteotropic as it did not increase progesterone production by luteal cells 
in vitro (Godkin et al., 1984). Rather, trophoblast proteins seem to function by 
blocking the production of uterine PGF2a (Stewart et al., 1989). This effect 
occurs by action of IFN., on the endometrial luminal epithelium to prevent rapid 
increase in oxytocin receptors (Flint et al., 1989; Bazer, 1992), which normally 
occurs just prior to luteolysis (Ayad et al., 1991; Wathes and Hamon, 1993). 
CONVERGENCE OF SIGNAL TRANSDUCTION SYSTEMS 
The Mitogen-activated Protein Kinase Cascade 
While it is certainly evident that both the protein kinase A and protein 
kinase C are important regulators of ovarian function, only recently have these 
signal transduction pathways been truly linked intracellularly. Both of these 
systems seem to converge at the newly elucidated mitogen-activated protein 
(MAP) kinase cascade, thus this series of phosphorylation events is a likely 
mediator of at least some of the actions of PICA and PKC. Three isoforms of 
MAP kinase are known to exist (Boulton et al., 1991) and at least two of them 40 
require phosphorylation for kinase activity (Anderson et al., 1990; Serger et al., 
1991). The enzyme is activated in response to a variety of stimuli including 
growth factors, insulin and other hormones. 
The involvement of receptor tyrosine kinases, such as those of insulin and 
epidermal growth factor, in the activation of MAP kinase has only been recently 
fully understood. Through their plasma membrane receptors, these agents 
directly or indirectly activate the cytoplasmic protein known as Ras. Ras, now 
bound to GTP, can activate the serine/threonine protein kinase Raf, which in 
turn phosphorylates MEK, or MAP kinase kinase. Ras activation is not 
obligatory in the activation of Raf, however, because protein kinase C can also 
positively affect Raf directly. It appears that PKA can also directly affect Raf, 
although whether this regulation is in a positive or negative manner depends on 
cell type and other factors. After activation of MEK, MAP kinase itself is then 
phosphorylated and events affecting transcription can occur (O'Brien, 1994). For 
example, one way that MAP kinase appears to be able to regulate gene 
expression is through phosphorylation of transcription factors such as c-myc 
(Seth et al., 1991) and c-jun (Pulverer et al., 1991). MAP kinase can also activate 
other proteins such as ribosomal S6 kinase (RSK-1) and PHAS-1. Ribosomal S6 
kinase can also phosphorylate transcription factors including serum response 
factor, Nur77, c-fos, c-jun and histone H3. Additionally, RSK-1 appears to be 
involved in cellular metabolism, playing a regulatory role in activation of 
glycogen synthesis (De Meyts et al., 1994). When phosphorylated, the protein 
PHAS-1 dissociates from eIF-4E, a factor that is required (in the unbound state) 
for initiation of protein synthesis (Lin et al., 1994). 
Several preliminary studies have directly investigated this cascade in the 
female reproductive tract. Davis et al. (1995) examined the role of the MAP 
kinase cascade in the PGF2a-induced secretion of transforming growth factor p1 41 
(TGF(3) from bovine luteal cells. They reported that the elements of the MAP 
kinase cascade were present in the bovine CL, including Raf-1, MEK, and three 
isoforms of MAP kinase. Both PGF2a and phorbol myristate acetate (PMA), an 
activator of PKC, stimulated phosphorylation, and thus activation of the p44 
form of MAP kinase, with subsequent dose-dependent release of TGFI3 from the 
cells. Their data support the premise that the PGF2c, and PMA-mediated 
secretion of TGFI3 ultimately depends on the MAP kinase activation of 
transcription factors, presumably including c-jun. Additionally, all elements of 
the MAP kinase cascade have been shown to be present in porcine granulosa, 
theca and luteal cells (Hildebrandt et al., 1995) and that hormonal stimulation of 
this cascade is possible at least in the porcine granulosa cell (Warren et al., 1995). 
Even though this pathway has only recently been elucidated, systems feeding 
into this pathway, such as hormonal activation of PKC and PKA have already 
been extensively studied. More recently some of the end points, such as 
induction of c-fos and c-jun in the female reproductive tract have come under 
investigation (see below). 
Early Response Genes and their Products in the Reproductive Tract 
C-jun is a nuclear protein that makes up part of the AP-1 transcription 
factor. AP-1 can be a homodimer of c-jun or a heterodimer of c-fos and c-jun. 
While the binding of the AP-1 homo- or heterodimer to its response element on 
DNA is the action that alters transcriptional activity of various genes, study of 
the regulation of the c-fos and c-jun genes is also of interest. They are called 
"early response genes", along with c-myc, because they respond quickly to 
hormonal and growth factor stimuli with increases in mRNA, thus subsequently 42 
allowing additional protein expression of the transcription factors. "Delayed 
response genes" are those that take an hour or more to induce, require new 
protein synthesis for induction, and are likely stimulated by the products of the 
early response genes (Alberts et al., 1994). 
The roles of several hormones on induction of early response genes in 
reproductive tissues have been studied. Several studies have focused on 
expression of c-jun in the uterus, a steroid-responsive portion of the reproductive 
tract. In ovariectomized rats, estradiol has been shown to induce c-jun gene 
expression (Cicatiello et al., 1993; Webb et al., 1993). In immature rat uterus, c-
jun expression also increased after estradiol injection (Webb et al., 1990; Bigsby 
and Li, 1994), however when RNA from different uterine compartments was 
analyzed, c-jun was actually repressed in the uterine luminal epithelium (Bigsby 
and Li, 1994). In mature rats, a stronger induction of c-jun was found 
specifically in the stroma-myometrial tissue (Webb et a1.,1990). These effects 
were also shown by Nephew et al. (1994) who found that expression of c-jun was 
increased by estrogen in uterine glands and myometrium of immature rats, but 
in mature rats the uterine glandular epithelium did not respond to estradiol with 
increased c-jun expression. Shelley et al. (1994) examined the induction of c-jun 
after tonic administration (via implants) of estradiol, progesterone or estradiol 
plus progesterone for 24 or 48 h. In this study, high dosage steroid treatment 
actually suppressed c-jun induction in the uterus by 48 h, although by 48 h 
expression in the ovaries and adrenals had increased. Thus, the role of 
expression of the early response genes in the uterus is somewhat equivocal, and 
their induction by steroids depends on timing and dosage of administration. At 
least in the immature rat uterus, no simple correlation exists between cellular 
proliferation and increased expression of the early response genes studied 
(Bigsby and Li, 1994). Additionally, the lack of maturational effects on c-jun 43 
gene expression, and the differential response of the mature vs. immature rat 
uterus to estrogen in terms of cell proliferation (Nephew et al., 1994), seem to 
indicate unexplored roles for early response gene expression in the uterus. 
Others studies have concentrated on early response gene induction in 
steroidogenic tissues. Both hCG and dbcAMP can transiently increase the levels 
of c-fos and c-myc mRNA in cultured mouse Leydig tumor cells (Czerwiec et al., 
1989). In rat granulosa cells, FSH and dbcAMP increased c-fos and c-jun 
message in 30 min on both day 0 and day 2 of culture three- to fourfold, but LH, 
hCG and tetradecanoylphorbol-13- acetate (TPA) only markedly increased 
mRNA levels on day 2 of culture (Ness and Kasson, 1992). Khan et al. (1993) 
examined how PGF2a could influence c-jun expression in the ovary, uterus and 
adrenal of pregnant mare serum gonadotropin (PMSG)-primed immature rats. 
Thirty minutes after a second injection of PGF2a, c-jun mRNA was increased in 
the ovary but not the uterus or adrenal. Induction of signal was stronger in 
corpora lutea on day 7 after ovulation than on day 3. Although not induced by 
PGF2a, c-jun mRNA was present in the adrenal, another steroid producing 
organ, but was barely detectable in the steroid-responsive uterus, whether from 
control or PGF2a-treated animals. In regard to its effect on the CL, the authors 
speculated that because the effect of PGF2a was stronger in older than in 
younger CL, c-jun expression might be linked to the mode of action of PGF2a in 
corpus luteum regression. In another study Khan et al. (1994) examined both c-
fos and c-jun expression in CL from PMSG-primed immature rats on day 7 post-
ovulation, at 15, 30 and 120 min after PGF2a or PGE2 injection. Injection of 
PGF2a and PGE2 induced a four- and twofold increase, respectively, in c-jun and 
c-fos expression. However, the effect on c-fos expression was transient and 
found only 15 min after prostaglandin injection, while message for c-jun 
remained elevated until 2 h post-injection. Expression of c-jun was threefold 44 
higher in the PGF2a-treated animals than in those injected with PGE2. From this 
study, the authors concluded that both luteotropic and luteolytic effects of these 
prostaglandins could involve activation of AP-1 responsive genes. All of the 
studies on hormonal regulation of the early response genes seem to indicate that 
they may be differentially regulated depending on cell type and stimulus, and 
that they could be very important in regulating nuclear events that ultimately 
control aspects of reproductive function. 
ROLE OF GnRH IN OVARIAN FUNCTION 
Mechanisms of Action 
In both males and females, administration of pharmacological doses of 
GnRH or its agonists results in an increase in serum gonadotropins. Because 
gonadotropins are important regulators of gonadal function, researchers have 
sought to determine if exogenous GnRH can enhance fertility. In reality, it 
seems that GnRH has the potential to inhibit reproductive function by 
decreasing ovarian steroid production, decreasing numbers of gonadotropin 
receptors, inhibiting follicular development, maturation, and ovulation, delaying 
ovum transport and implantation, decreasing uterine growth and possibly 
terminating pregnancy (Hsueh and Jones, 1983). 
At least three mechanisms, proposed by Hsueh and Jones (1983), can 
potentially account for the alteration of gonadal function by GnRH. One is that 
chronic stimulation or high doses of GnRH may cause a desensitization of the 
gonadotropes in the pituitary (Belchetz et al., 1978), causing decreased 
gonadotropin secretion and thus loss of gonadal function. This does not appear 45 
to be true, however, at least for the effect of a somewhat acute administration of 
GnRH in the cow, because injection of 100 pg GnRH on both days 2 and 8 of the 
same estrous cycle caused a significant increase in secretion of LH on both days 
(Martin et al., 1990). Continuous administration of GnRH also does not appear 
to affect basal secretion of LH, nor responsiveness of the pituitary to bolus 
injections of GnRH. Lamming and McLeod (1988) continuously infused GnRH 
s.c. into cows for 14 days at 20 µg /hour. Within 48 h of the start of infusion, LH 
levels returned to pre-infusion concentrations. However, a bolus injection of 10 
GnRH i.v. both before the start of infusions and on the fourteenth day of 
infusion caused an increase in plasma concentrations of LH, although the release 
after the second injection was significantly less than the release after the first. 
These results do indicate that the pituitary was still responsive to GnRH even 
after a long period of continuous exposure to GnRH. 
A second possibility is that GnRH injection can stimulate the release of 
large quantities of LH, causing desensitization of gonadal cells to subsequent 
action of LH. In relation to the CL, a number of studies have shown that, at 
various times during the estrous cycle, GnRH injection can rapidly cause a 
significant increase in serum concentrations of LH in both the cow (Milvae et al., 
1984; Rodger and Stormshak, 1986; Martin et a1.,1990) and the ewe (Slayden and 
Stormshak, 1990, Whitmore, 1995). Rodger and Stormshak (1986) suggested that 
a GnRH-induced LH surge on day 2 of the cycle may indeed cause down-
regulation of luteal LH receptors, because they found a significant decrease in 
receptor number on days 8 and 14 of the same cycle. It does not appear, 
however, that simply a decrease in luteal LH receptors fully explains alteration 
of luteal function by GnRH. Martin et al. (1990) showed that serum 
concentrations of progesterone did not differ between cows that had received 
injections of saline or GnRH on days 2 and 8 of the cycle, whereas Rodger and 46 
Stormshak (1986) showed that a single GnRH injection on day 2 significantly 
reduced serum progesterone beginning on day 8 compared with saline controls. 
Thus it appears that in the double-injection study sufficient LH receptors were 
available to support the luteotropic action of this gonadotropin; the extra 
endogenous LH secreted in response to the exogenous GnRH on day 8 may have 
helped maintain luteal function. 
Milvae et al. (1984) also reported that repeated injections of GnRH 
analogue on days 9 through 12 of the estrous cycle caused an increase in serum 
LH, at least initially, and actually increased serum progesterone during the same 
cycle when compared with saline-treated controls. However, serum 
concentrations of progesterone were depressed in the subsequent cycle. In the 
same study, repeated injections of native GnRH also initially caused significant 
increases in serum LH, although actual concentrations were slightly lower than 
with the analogue, but no effect was detected relative to serum progesterone. 
The authors postulated that this slightly lowered response of LH could cause the 
differences observed in serum concentrations of progesterone, or that GnRH 
analogue caused LH and FSH to be released in a different pattern than the native 
hormone. Thus timing and type of administration may affect actions of GnRH 
on the pituitary and almost certainly affect its actions on luteal function. 
The third proposed mechanism is that GnRH acts directly on the ovary (or 
testis). This seems to be true in rats because high affinity binding sites for GnRH 
have been found in the ovaries (Clayton et al., 1979) and testis (Labrie et al., 
1980) of this species. The receptor binding characteristics of these sites have 
been shown to be identical to those of the pituitary (Reeves et al., 1980). Clayton 
et al. (1979) additionally showed that these receptors are functional because 
basal progesterone production by isolated luteal cells decreased 25% when the 
cells were incubated with GnRH analogue. Stimulation of progesterone by low 47 
levels of hCG was completely abolished in the presence of the analogue. 
Response of the cells to hCG could be attained, but the amount needed for 50% 
maximal stimulation was increased 25-fold in the presence of GnRH analogue. 
The effect was most likely mediated by the GnRH receptor because binding of 
hCG to the cells was not affected. Messenger RNA levels for the GnRH receptor 
in rat ovaries has also been recently examined (White law et al., 1995). 
Expression of GnRH receptor in granulosa cells appeared to be individually 
regulated for each follicle, and was present in the corpus luteum and atretic 
follicles. 
In other species, it is not clear if GnRH can act directly on the ovary. 
Brown and Reeves (1983) showed that GnRH binding sites were not present on 
follicles or corpora lutea of cows, ewes or sows, using rat ovaries as well as 
pituitaries from these animals as positive controls. Other researchers were 
unable to demonstrate binding of GnRH to gonadal tissue of other species, such 
as monkey (Asch et al., 1981), human (Clayton and Huhtaniemi, 1982) and 
mouse (Hunter et al., 1982). Recently, however, GnRH receptor mRNA has been 
found to be expressed in human granulosa cells in culture, using reverse-
transcription polymerase chain reaction (RT-PCR), a method that can detect very 
low levels of transcript (Peng et al., 1994). The authors described these cells as 
granulosa-luteal cells, although no in vitro differentiation process was described. 
Additionally, Peng et al. (1994) detected the presence of mRNA for GnRH itself 
in these cells. They found that GnRH regulated the expression of its receptor as 
well as its own message, with effects dependent on GnRH dosage. 
It remains to be determined if mRNA for GnRH or the GnRH receptor 
can be detected in ovarian tissue of domestic animals. However, GnRH-like 
peptides have been found in bovine (Aten et al., 1987a; Ireland et al., 1988), 
ovine (Aten et al., 1987a) as well as rat (Aten et al., 1986) and human ovaries 48 
(Aten et al., 1987b). These peptides appear to compete for GnRH binding sites 
but are not cross-reactive with GnRH antibodies. It is not clear whether these 
GnRH-like peptides have any real physiological role in regulating ovarian 
function. 
The most likely route by which exogenous GnRH alters luteal function in 
domestic animals is indirectly via the endogenous release of LH. As discussed 
above, GnRH given at various times during the estrous cycle causes a rise in 
systemic LH. To examine how GnRH might act on the corpus luteum, Slayden 
and Stormshak (1990) on day 2 of the cycle injected GnRH directly into the 
artery of the ovary bearing the corpus luteum in ewes. In one experiment 
injection of 25 lig GnRH into the ovarian artery caused a reduction in serum 
concentrations of progesterone on days 7 through 11 of the cycle compared with 
saline-injected controls. This dosage, however, was actually high enough to 
cause a significant increase in systemic LH in response to the GnRH. When a 
second experiment was conducted using 50 ng of GnRH injected into the ovarian 
artery, no rise in LH and no change in serum concentrations of progesterone was 
found. Thus, it appears that GnRH most likely alters progesterone production 
by the corpus luteum in vivo by acting through an endogenous LH surge rather 
than directly on the ovary. This was further confirmed in a third experiment, 
when repeated injections of LH were given on day 2 via the jugular vein to 
mimic the serum profile of LH following a GnRH injection. In this experiment, 
serum progesterone concentrations were significantly depressed on days 6 and 8 
of the estrous cycle (treatment x day interaction). Milvae et al. (1984) also 
attempted to examine local effects of GnRH on luteal function by using an 
intrauterine infusion of GnRH. Intrauterine infusion of 100 1.1g GnRH twice daily 
on days 12, 13 and 14 of the estrous cycle did increase jugular concentrations of 
LH, but plasma progesterone was not affected. The same study, however, did 49 
show that a high dose of GnRH could directly depress progesterone production 
by isolated bovine luteal cells in vitro (Milvae et al., 1984). The decrease in 
progesterone was only detected at a high dose of GnRH (100 ng). The authors 
postulated that perhaps a non-receptor mediated mechanism was responsible for 
the inhibitory effect of the GnRH in vitro. 
Practical Applications 
The role of GnRH in altering ovarian or luteal function is of interest to 
animal producers, who could use it as a tool for enhancing reproductive 
efficiency (or who could avoid its use if it is detrimental to certain aspects of 
reproduction). Casida et al. (1944) first reported that sheep pituitary extract rich 
in LH could be used for treatment of ovarian cysts in cattle. Human chorionic 
gonadotropin, which possesses LH activity (Mason et al., 1962), was previously 
the most commonly used agent to treat ovarian cysts. Because injection of GnRH 
is known to cause a release of LH from the pituitary, GnRH was also found to 
rid animals of follicular cysts (Kittok et al., 1973; Bierschwal et al., 1975; Cantley 
et al., 1975; Seguin et al., 1976). Treatment with GnRH cures ovarian cysts in 
approximately 70 to 80% of cows, whether the cysts are of follicular or luteal 
origin. However, if the presence of a luteal cyst can be accurately determined, 
the use of PGF2c, or an analogue is recommended over the use of GnRH 
(Archbald et al., 1991). 
Seguin et al. (1977) performed experiments to determine what effect hCG 
and GnRH would have on estrous cycle length in the event of a misdiagnosis of 
cystic ovaries (i.e., if the animal was actually in the luteal phase of the cycle). 
Repeated injections of hCG had been shown to be luteotropic and extend estrous 50 
cycle length in cycling animals (Wiltbank et al., 1961; Moody et al., 1971; 
Veenhuizen et al., 1972), while a preliminary study (Britt, 1975) had shown that 
injection of GnRH into heifers on days 15, 17 or 19 did not affect estrous cycle 
duration, although behavioral estrus was inhibited in some of the animals 
injected on day 19. Seguin et al. (1977) injected heifers with saline, 100 .tg GnRH 
or 10,000 U hCG on day 10 or 11 after estrus. In one experiment, they found that 
injection of hCG on day 10 or 15, but not day 17, prolonged luteal function and 
thus increased estrous cycle length by approximately 4 to 7 days. In a second 
experiment, administration of hCG on day 10 or 11 again extended the length of 
the estrous cycle, while GnRH did not alter estrous cycle length when compared 
with saline controls. Also, hCG, but not GnRH, increased serum progesterone 
between time of injection and estrus. Because the purpose of rupturing ovarian 
cysts is to allow the animal to return to estrus more quickly, they deemed the use 
of GnRH rather than hCG to be, generally, the better treatment for ovarian cysts, 
especially in the event of misdiagnosis. The only disadvantage of GnRH 
compared to hCG was that in previous studies GnRH injection during proestrus 
inhibited signs of behavioral estrus, although ovulation was not affected (Britt, 
1975; Convey et al., 1976). Milvae et al. (1984) showed that repeated injections of 
GnRH analogue (but not native GnRH) during diestrus also increased cycle 
length, another example that type of injection and route or frequency of 
administration can contribute to differences in effects of the decapeptide. 
Gonadotropin-releasing hormone has often been used at the time of 
artificial insemination in cattle. A number of studies have been conducted to 
examine how GnRH given at this time or at other times during the cycle affects 
conception or pregnancy rates as well as luteal function. Schels and Mostafawi 
(1978) claimed that GnRH injection into cows at the time of first postpartum 
insemination tended to increase the first service conception rate (p<0.18) as well 51 
as the total pregnancy rate after three inseminations (saline control: 73.4% 
pregnant, GnRH: 81.6% pregnant; p<0.2). Injection of 5 lig of Buserelin, a potent 
GnRH analogue, was without effect on first insemination pregnancy rates when 
injected once between days 1 to 13 post-insemination (Macmillan et al., 1986). 
However 10 lig Buserelin increased pregnancy rates when given on days 11 to 
13, but not days 7 to 10, post-insemination. Total pregnancy rates after the 
second insemination were also greater in animals that had received Buserelin 
during days 11 to 13 post-first-insemination. Stevenson et al. (1984) examined 
the effect of GnRH given at time of first, second or third service artificial 
insemination after PGF2a-induced luteal regression. They found that conception 
rate at second and third service tended to be higher in those animals injected 
with GnRH at the time of artificial insemination, with GnRH injection having no 
effect on first service conception rates (unlike the studies mentioned above) 
Serum concentrations of progesterone in the GnRH-treated animals were 
decreased during the first 21 days post-estrus. In another set of studies Mee et 
al. (1993) found that GnRH administration at time of artificial insemination 
increased pregnancy rates on days 42 to 56 post-insemination in cows eligible for 
third service. In this study, serum concentrations of progesterone were higher 
on days 4 to 8, and up to 40 days after treatment (during pregnancy) in cows 
injected with GnRH when compared with saline-injected controls. 
Ellington et al. (1991) examined the effect of Buserelin injection on 
pregnancy rates in heifers used as embryo transfer recipients. Embryos were 
transferred on day 7 to 8 post-estrus and recipients received Buserelin injection 
at time of transfer or 4 to 7 days post-transfer. In this study no effect of Buserelin 
injection on pregnancy rates at days 35 to 60 post-insemination was detected. 
Effects of GnRH on conception and embryo survival in other species has 
been examined as well. Injection of GnRH at time of mating of pubertal gilts 52 
was found to increase number of ovulations, but was without effect on number 
of conceptuses and number of viable fetuses (Archibong et al., 1987). In ewes, 
preliminary studies indicated that injection of Buserelin 13 or 14 days after 
natural service increased lambing rate by 10% (unpublished data cited in 
Macmillan et al., 1986). 
The mechanism by which GnRH might influence conception rates or 
embryonic survival is still unclear. Lucy and Stevenson (1986) suggested that 
the action of GnRH must be mediated by some other means than augmenting 
serum concentrations of progesterone in treated animals. This assumption seems 
to be correct, as various studies report both increases and decreases in serum 
progesterone after GnRH administration, while conception rates tend to be 
improved in either case. 53 
STATEMENT OF THE PROBLEM  
Embryonic mortality is of great concern to animal agriculture; it is 
estimated that 25 to 55% of all embryos die during early gestation (Niswender 
and Nett, 1994). Reproductive failure is considered to be one of the most costly 
and limiting factors in the livestock industry (Roberts et al., 1990). Some of these 
losses can be accounted for by genetic defects of the embryo itself, or 
environmental factors such as nutrition or climate, but maternal problems, 
especially of an endocrine nature, can be factors as well (Sreenan and Diskin, 
1983). Animals known as "repeat breeders" who fail to conceive or maintain 
early pregnancy, and thus continue to cycle and are available for repeated 
breeding, certainly contribute to this loss. 
Inadequate luteal function has been proposed as one mechanism by 
which animals fail to maintain early pregnancy. Kimura et al. (1987) suggested 
that delayed formation of the corpus luteum, either combined or not combined 
with lowered secretion of progesterone during the luteal phase, is one of the 
causes of repeat breeder syndrome. However, the primary function of the 
corpus luteum is to produce the steroid hormone progesterone, which prepares 
the uterus for implantation and helps maintain further luteal function and 
pregnancy. A need for adequate amounts of progesterone in early pregnancy is 
well established (Wilmut et al., 1985) and insufficient progesterone has been 
implicated in some studies as a factor in abnormal embryo development and 
early embryonic death (Sreenan and Diskin, 1983; Lamming et al., 1989). Thus 
the study of factors regulating corpus luteum function, including those affecting 
production of progesterone, are of importance for animal production. 
Gonadotropin-releasing hormone has been used as one tool to combat 
economic losses due to repeat breeder syndrome and early embryonic death in 54 
cattle (Schels and Mostafawi, 1978; Stevenson et a1.,1984; Lucy and Stevenson, 
1986; Macmillan et al., 1986 ; Mee et a1.,1993), although its effects on serum 
concentrations of progesterone have been variable (Stevenson et a1.,1984; Lucy 
and Stevenson, 1986; Rodger and Stormshak, 1986, Mee et al., 1993). Thus 
further study of how GnRH affects corpus luteum function is warranted. 
Mechanisms regulating luteolysis are also of interest, because if an animal fails 
to become pregnant, the corpus luteum needs to regress at the appropriate time 
in order to ensure a new cycle, and thus the potential for a new pregnancy. 
Early administration of GnRH seems to increase the large luteal cell to small 
luteal cell ratio in the corpus luteum (Mee et al., 1993).  Products of the large 
luteal cell (e.g., oxytocin) are thought to be pivotal in the luteolytic process. 
Thus it is appropriate to examine whether GnRH given early in the estrous cycle 
can alter responses of the CL during luteal regression. 55 
IN VITRO BOVINE LUTEAL PROGESTERONE PRODUCTION  
AFTER TREATMENT WITH GONADOTROPIN-RELEASING  
HORMONE IN VIVO  
INTRODUCTION 
Ford and Stormshak (1978) first observed that injection of gonadotropin-
releasing hormone (GnRH) into cows during metestrus reduced serum 
concentrations of progesterone later in the estrous cycle. This effect was 
confirmed by Rodger and Stormshak (1986), who found that when GnRH was 
injected on day 2 of the estrous cycle, serum progesterone levels were lower than 
saline-treated controls beginning on day 8 of the cycle. The effect of GnRH on 
the corpus luteum appears to be indirect, at least in domestic animals. Brown 
and Reeves (1983) found no evidence for GnRH receptors on corpora lutea or 
follicles of cows, ewes or sows. They confirmed that the rat ovary does contain 
binding sites for GnRH. Additionally, Slayden and Stormshak (1990) found that, 
in ewes, injection of luteinizing hormone (LH) could mimic the effect of GnRH 
injection on serum progesterone levels later in the cycle, thus supporting the idea 
that the effects of GnRH injection in ruminants is due to a GnRH-induced LH 
surge. 
The mechanisms of action of GnRH-induced alteration of luteal function 
are still unclear. Rodger and Stormshak (1986) found that GnRH injection on 
day 2 reduced number of luteal LH receptors on days 8 and 14 of the cycle and 
proposed this could directly be a reason for the altered luteal function, or that 
this could indicate more large luteal cells (and thus fewer LH receptors ) were 
present in GnRH-exposed corpora lutea. Mee et al. (1993) confirmed this latter 
hypothesis; they found an increased large luteal cell to small luteal cell ratio in 56 
CL of cows that had received GnRH 12 h after the onset of estrus. That study 
did not, however, rule out potential alteration in luteal function at the cellular 
level. In the present study, two experiments were conducted to further examine 
the action of exogenous GnRH on luteal cell function. More specifically, whether 
plasma membrane-related events contribute to altered luteal function, and 
whether large and(or) small luteal cells are functionally different in corpora 
lutea of animals exposed to GnRH compared with control animals. 
MATERIALS AND METHODS 
Experiment 1 
Experiment 1 was conducted to determine if luteal cell membrane-related 
events contribute to attenuated progesterone production by corpora lutea of 
GnRH-treated heifers. Beef heifers of mixed breeds were checked twice daily for 
estrus using a vasectomized bull. On day 2 of the estrous cycle (estrus = day 0 of 
the cycle), animals were injected i.v. with 2 ml sterile saline (0.9% NaCl) or 
GnRH (Cystoreline, 50 µg /ml, Sanofi Animal Health, Overland Park, KS; n = 5 
animals per group). 
On day 7, animals were restrained for surgery to remove the corpus 
luteum (CL). Caudal epidural anesthesia was induced by injection of 4 ml 
lidocaine hydrochloride (2%) into the coccygeal spinal column and an incision 
was made in the vagina through which the CL was removed. Corpora lutea 
were transported to the laboratory in sterile, phenol red-free Ham's F-12 
medium [Nutrient Mixture F-12 (Ham), Gibco Laboratories, Inc., Grand Island, 
NY] containing 14 mM sodium bicarbonate, 24 mM HEPES and 301Ag/m1 57 
gentamicin (Gibco), pH 7.3. For determination of adenylyl cyclase activity, 
approximately 100 mg of tissue were homogenized in 2 ml sucrose buffer [27% 
sucrose (w/w), 1 mM EDTA, 10 mM Tris, pH 7.5], immediately frozen in liquid 
nitrogen and stored at -80°C until the enzyme activity assay was performed. 
The remainder of the CL was sliced to 0.3 mm thickness, washed three 
times in medium, and aliquoted to eight 10 ml Erlenmeyer flasks (approximately 
100 mg per flask), each containing 2 ml incubation medium. Incubation medium 
consisted of Ham's F-12 (as described above) plus 5 pg /ml insulin, 5 pg/m1 
transferrin and 5 ng/ml selenium (ITS, Sigma Chemical Co., St. Louis, MO). 
Treatments were then added to each flask: 20 pl saline were added to four flasks 
(two unincubated controls, two incubated controls), two flasks received bovine 
LH dissolved in 20 IA saline (final concentration: 50 ng/ml; USDA-bLH-B-6, 
USDA Animal Hormone Program, Beltsville, MD), and 8-bromo-cAMP (Sigma) 
was added to two flasks at a final concentration of 15 mM. Flasks were gassed 
with 95% 02-5% CO2 for several seconds each and capped with silicone 
stoppers. An additional 2 ml of cold ethanol was then immediately added to the 
two unincubated control flasks to preclude further progesterone synthesis. Two 
additional milliters of ethanol were used to rinse the flask. The remaining flasks 
were incubated for 2 h at 37°C in a Dubnoff shaking water bath. After 2 h, cold 
ethanol was added to these flasks to terminate the incubation. Tissue plus 
medium samples were stored at -20°C until extraction and determination of 
progesterone content by radioimmunoassay. 58 
Experiment 2 
Experiment 2 was conducted to examine whether functional differences 
between large and(or) small luteal cells of saline vs. GnRH-treated heifers may 
contribute to altered progesterone production by GnRH-exposed corpora lutea. 
Beef heifers were checked twice daily for estrus using a vasectomized bull. On 
day 2 of the estrous cycle, 2 ml saline or 2 ml GnRH (10011,g) were injected i.v. as 
in Experiment 1 (n = 5 animals per treatment). 
On day 7, a blood sample was taken for determination of serum 
concentration of progesterone and the CL removed via vaginal incision as 
described for Exp. 1. The CL was transported to the laboratory in Ham's F-12 
where it was dissected free of connective tissue in a sterile cell culture hood. The 
tissue was then dissociated according to a modification of the procedure by Pate 
and Condon (1983). The CL was cubed into 1 mm pieces and minced finely with 
surgical scissors for 5 to 10 min in medium containing 0.5% bovine serum 
albumin (BSA, Sigma). Tissue was rinsed several times with medium and 
dissociated in a spinner flask for 1 h at 37°C in 20 to 25 ml 0.5% BSA medium 
containing 2000 U collagenase (CLS 1, 142 U/mg, Worthington Biochemical 
Corp., Freehold, NJ) per gram tissue. Tissue and medium were aspirated 5 to 10 
times every 10 min during dissociation to aid in dispersion of cells. At the end 
of 1 h, cells were transferred to two 15 ml sterile centrifuge tubes and 
centrifuged at 150 x g for 15 min to remove collagenase. Supernatant was 
removed and cells resuspended in 0.5% BSA medium. Cells were washed again 
at 85 and 65 x g in a similar fashion. Cells were counted on a hemocytometer 
using the trypan blue dye exclusion method (Patterson, 1979) for determination 
of live and dead luteal cell numbers. 59 
An aliquot (7.5 x 106 luteal cells) was removed and adjusted to a volume 
of 50 ml with 0.5% BSA medium for cell separation. The remaining cells were 
kept on ice in 0.5% BSA medium during the cell separation procedure. Cells 
were separated by sedimentation at unit gravity in an Eppendorf CelsepTM 
apparatus (Brinkmann Instruments, Inc., Westbury, NY) according to a 
modification of the procedures by Weber et al., (1987) and Dr. Gary Williams 
(Texas A&M University Agricultural Research Station, Beeville, TX, personal 
communication). A gradient of approximately 880 ml Ham's F-12 medium 
containing 1 to 2% BSA was created in the one liter separation chamber, with an 
underlay of 20% BSA medium. The cells in 0.5% BSA medium were loaded on 
top of the gradient; an overlay of 25 ml Ham's F-12 without BSA was loaded on 
top of the cells. Separation occurred for 1 h 15 min. During separation, the cell 
culture hood was shut off to avoid vibration. After separation, ten 15 ml and 
sixteen 50 ml fractions were collected into sterile centrifuge tubes. Cells were 
centrifuged at 150 x g for 10 min and most of the medium was decanted. 
Dissociated cells that were previously held on ice were also centrifuged, then 
resuspended in Ham's F-12. Fractions from the cell separation were examined 
under a microscope using an ocular micrometer to determine cell types in each. 
Fractions containing small luteal cells (approximately 15 to 22 pm) with as few 
contaminating larger or smaller cells as possible were combined, an aliquot 
counted via hemocytometer, and then resuspended in Ham's F-12. 
Both dissociated (mixed) and separated small luteal cells were plated onto 
one 6 well plate each (Corning Glass Works, Corning, NY). Cell culture plates 
used had earlier been serum-coated at 37°C for 1 to 4 h with Ham's F-12 
containing 10% calf serum (Sigma), then rinsed 2 to 3 times with fresh medium 
before cells were added. Approximately 0.5 to 0.75 x 106 cells were added to 
each well in a final volume of 3 ml Ham's F-12 containing ITS. Cells were 60 
incubated overnight at 37°C in a humidified incubator with a 5% CO2 
atmosphere. The following day, the medium was removed from all wells and 3 
ml fresh medium with TTS were added. Treatments were added in duplicate to 
wells containing small and mixed cells. Treatments consisted of: control 
(medium alone), LH (50 ng/ml) and 8-bromo-cAMP (15 mM). Cells were 
incubated for 2 h; the media from each well were then recovered and stored 
frozen at -20°C until analysis for progesterone. Additional Ham's F-12 was 
added to each well and cells were counted using a Nikon TMS inverted phase 
light microscope at 200X magnification. Large and small cells were 
distinguished morphologically. 
Progesterone Radioimmunoassay 
Tissue plus medium from Exp. 1 were extracted by modification of the 
procedure described by Koligian and Stormshak (1976). Each sample (tissue 
plus medium) was placed into a Duall ground glass homogenizer after addition 
of 20,000 cpm of [3H]progesterone (Dupont NEN®, Boston, MA) to the sample 
storage vial. The sample storage vial was rinsed three times with 2 ml ethanol 
and the sample homogenized. The homogenate was poured over Whatman No. 
1 filter paper, which was held in a glass funnel, and allowed to filter through 
into round bottom flasks. The glass homogenizer and pestle were rinsed four 
times with 2 ml ethanol and these rinses were added to the filter paper. The 
filter paper was rinsed five times with 2 ml ethanol and allowed to dry; the filter 
was then removed and the glass funnel and inner neck of the flask were rinsed 
with ethanol. Flasks were roto-evaporated at 45°C until samples were nearly 
dry, then 3 ml distilled water were added and the samples vortexed for 30 sec. 61 
Samples stood at room temperature for 30 min and were then vortexed for 2 min 
after the addition of 20 ml benzene:hexane (1:2). After storage at -20°C 
overnight, the organic phase was decanted and dried under air. Samples were 
resuspended in 20 ml ethanol and a 1 ml aliquot was removed to determine 
extraction efficiency. Sera from Exp. 2 were also extracted similarly by vortexing 
for 30 sec with 2 ml benzene:hexane (1:2) and dried down for use in the assay, 
while media progesterone concentrations (Exp. 2) were determined by 
radioimmunoassay without extraction. The mean extraction efficiency for tissue 
plus medium samples from Exp. 1 was 68.7±0.8%. Each tissue plus medium 
sample was corrected using its specific extraction efficiency. Mean extraction 
efficiency for serum from Exp. 2 was 88.7%, which was used as a correction 
factor for all samples. 
Radioimmunoassay was performed using progesterone standards ranging 
from 5 pg/100 pl to 800 pg/1001.il in ethanol. Ethanol standards (100 p.1, in 
triplicate) or diluted sample (100  in duplicate) were pipetted into 12 x 75 mm 
glass test tubes and evaporated. One hundred microliters of phosphate buffered 
saline with gelatin (GPBS; 0.01 M NaPO4 pH 7.0, 0.14 M NaC1, 1:10,000 
thimerosol, 0.1% gelatin) was then added to all tubes. Aqueous (media) samples 
(100 pl) were not evaporated; an additional 100 41 of GPBS were added to all 
other tubes to compensate for the additional volume. Anti-progesterone-11-BSA 
(Dr. Gordon Niswender, Colorado State University, Fort Collins, CO) in 100111 
GPBS was added to each standard and sample tube in a 1:3500 dilution. Tubes 
were incubated 30 min at room temperature and 20,000 cpm [3H]progesterone in 
100 IA GPBS were then added to each tube. Tubes were vortexed then incubated 
overnight at 4°C. The following day, 1 ml of dextran-coated charcoal [2.5 g/1 
washed neutral norit charcoal (Sigma), 0.25 g/1 Dextran T-70 (Pharmacia, 
Uppsala, Sweden)] in GPBS was added rapidly to each tubes. Tubes were 62 
vortexed and incubated at 4°C for 15 min, then centrifuged at 2540 x g for 10 
min. The supernatant from each tube was poured into a 20 ml glass scintillation 
vial and 6 ml of Ecolume scintillation cocktail (ICN, Costa Mesa, CA) were 
added. Samples were counted in a Beckman LS-6000 liquid scintillation counter. 
Standard curves were plotted and unknown concentrations determined using 
the RIA AID computer program (Robert Maciel Associates, Inc., Arlington, MA). 
Intraassay and interassay coefficients of variation were determined using a 75 
pg/100 pl sample in ethanol (18 tubes per assay), and for Exp 1. were 10.1±0.5% 
and 3.8% (n = 7 assays), and for Exp. 2 were 10.9±0.7% and 6.8% (n = 8 assays), 
respectively. 
Adenylyl Cyclase Activity Assay 
Adenylyl cyclase activity was measured in luteal homogenates by 
modification of procedures by Agudo et al. (1984) and Birnbaumer et al. (1988). 
All chemicals were purchased from Sigma Chemical Co. unless otherwise noted. 
Each sample (50 pl) was incubated in the presence of 10 µ110X incubation 
mixture, pH 7.3 [0.5 mM HEPES, 50 mM MgSO4, 20 mg/ml BSA, 10 mM cAMP 
and 1 x 107 cpm [3H]cAMP (Dupont NEN)], 10 µ110X regeneration mixture [40 
mM creatine phosphate, 25 units creatine phosphokinase (Calbiochem, San 
Diego, CA)] and 20 µ15X ATP [0.5 mM containing approximately 1 x 106 cpm [a 
-32P]ATP (Dupont NEN)] in a total volume of 100 pl .  Actual specific activity of 
the 5X ATP mixture was determined by use of a spectrophotometer (ATP 
concentration) and the liquid scintillation counter (radioactivity). Adenylyl 
cyclase activity was determined in both the presence (activated) and absence 
(non-activated ) of 0.1 mM GTPyS, each in duplicate for each luteal sample. A 63 
reaction mixture without luteal homogenate was incubated with each set of 
samples as a reaction blank to determine non-specific incorporation. Reaction 
mixtures were incubated for 10 min at 30°C and the reaction stopped with 1 ml 
0.17 N perchloric acid. 
Stopped reaction mixtures were transferred onto individual Econo-pak 
glass columns 0.5 cm I.D., 15 cm long (Bio-Rad Laboratories, Hercules, CA) 
containing AG 50W-4X, 200-400 mesh, H+ form resin (Bio-Rad) which had been 
subjected to three regeneration cycles (one cycle = 20 ml H2O, 20 ml 2 N NaOH, 
20 ml H20, 20 ml 2 N HC1 then 60 ml H2O) before use. After the reaction 
mixture filtered into the resin bed, 1 ml then 2.5 ml H2O were added to the top 
of the column. Each column was then placed above another glass column 
containing 1.2 g alumina oxide which had been rinsed with 10 ml 0.1 M 
imidazole-HC1, pH 7.5, before use. Samples were eluted from the resin column 
with 4 ml H2O and allowed to drip into the alumina oxide column. Once the 
water had passed through the alumina oxide column, 1 ml of imidazole buffer 
was added to each column. Cyclic AMP was eluted into 20 ml scintillation vials 
by addition of 4 ml imidazole buffer. Fifteen milliliters of Ecolume were added 
to each vial and samples were counted using the liquid scintillation counter. 
[3H]cAMP in eluted samples and in the original 10X incubation mixture were 
used to determine percentage recovery. [32P]cAMP in the samples was used to 
determine conversion from [32P]ATP with [32P] in the reaction blank subtracted 
from each sample. Protein concentration in each luteal homogenate was 
determined using the Bio-Rad protein assay and adenylyl cyclase activity was 
expressed as cAMP formed in pmol.min-l.mg protein-1. 64 
Statistical Analysis 
Progesterone data for both experiments were analyzed by ANOVA using 
the general linear model procedures of SAS (1993). Treatment duplicates were 
averaged and the mean values used for statistical analysis. In Exp. 1, 
progesterone data were analyzed as a split-plot design, after subtraction of each 
sample's corresponding unincubated control, with GnRH, animal(GnRH), in 
vitro treatment and GnRH x in vitro treatment included as sources of variation. 
Animal(GnRH) was used as the error term to test the significance of GnRH 
injection. Only the GnRH effect is presented in the results because there were no 
GnRH x in vitro treatment interactions. Differences among specific treatment 
means were determined by Least Significant Difference test. Differences 
between mean non-activated or activated adenylyl cyclase activities were 
determined by t-test using Statgraphics (STSC, Inc., Rockville, MD). 
For Exp. 2, progesterone data were analyzed as a split-split-plot using 
GnRH, animal(GnRH), cell type, GnRH x cell type, cell type x animal(GnRH), in 
vitro treatment, GnRH x in vitro treatment, cell type x in vitro treatment and 
GnRH x cell type x in vitro treatment as sources of variation. GnRH was tested 
for significance using animal(GnRH) as the error term; cell type and GnRH x cell 
type were tested against cell type x animal(GnRH) as the error term. Differences 
among treatment group means were determined using the contrast procedure of 
SAS. The percentages of large cells present in the mixed cell cultures were 
analyzed independently as a split-plot design with SAS, using GnRH, 
animal(GnRH), in vitro treatment and GnRH x treatment as sources of variation. 
GnRH was tested for significance using animal(GnRH) as the error term. Serum 
concentrations of progesterone for Exp. 2 were analyzed by t-test with 
Statgraphics. Statistical consultation for Exp. 1 was provided by Dr. Ken Rowe, 65 
and for Exp. 2 by Dr. David Thomas, both of the Department of Statistics, 
Oregon State University. 
RESULTS 
In Exp. 1, GnRH injection on day 2 significantly reduced progesterone 
production by luteal slices on day 7 of the cycle in response to LH (p<0.01) and 
cAMP (p<0.001) but did not affect basal progesterone production by the tissue 
slices (p>0.05; Figure 1). There were overall effects of GnRH to decrease 
progesterone production (p<0.05) and of the LH and cAMP in vitro treatments to 
stimulate progesterone production (p=0.0001). Neither non-activated adenylyl 
cyclase activity nor that activated with GTPyS was affected by in vivo injection 
with GnRH (p>0.05; Figure 2). 
In contrast, progesterone production in Exp. 2 by small or mixed luteal 
cells in response to LH or cAMP was not affected by in vivo administration of 
GnRH (p>0.05; Figure 3A). There was an overall effect of in vitro treatment 
(p=0.001); LH and cAMP stimulated progesterone production compared to in 
vitro controls (saline: small cells p<0.002, mixed cells p=0.001; GnRH: small cells 
p<0.001, mixed cells p<0.001). Also, mixed cell cultures had higher progesterone 
production than small cell cultures (p<0.001), although small cells appeared to 
have greater response to the in vitro treatments when data were expressed as a 
percentage of the respective in vitro controls (Figure 3B). When numbers of large 
cells present in the mixed cell cultures (expressed as a percentage of total cells) 
were analyzed, there were no differences between GnRH and saline injections 
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Figure 1.  In vitro progesterone production by day 7 luteal slices from beef 
heifers injected with saline or GnRH on day 2 of the estrous cycle. Treatments 
imposed in vitro were LH (50 ng/ml) and 8-bromo-cAMP (15 mM). The overall 
effects of GnRH injection (p<0.05) and in vitro treatments (p=0.001) were 
significant. In vivo administration of GnRH reduced progesterone production by 
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NON-ACTIVATED  ACTIVATED 
Figure 2. Adenylyl cyclase activity in corpora lutea of beef heifers injected with 
saline or GnRH expressed as pmol cAMP formed.min-l.mg protein-I.  The 
enzyme assay was performed without (non-activated) or with (activated) the 
addition of 0.1 mM GTPyS.  Administration of GnRH was without effect on 
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IN VITRO TREATMENT 
Figure 3A.  Progesterone production by small and mixed luteal cell cultures 
from corpora lutea of beef heifers injected early in the estrous cycle with saline
or GnRH.  In vitro treatment with LH or cAMP significantly  stimulated 
progesterone production compared with controls (p<0.005); however, in vivo 
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Figure 3B.  Data from Fig. 3A presented as a percentage of in vitro control 
treatment. 70 
of the cycle did not affect serum progesterone on day 7 in the present study 
(saline: 2.55±0.48 ng/ml; GnRH: 2.84±0.21 ng/ml; p>0.05). 
DISCUSSION 
Results from Exp. 1 suggest two potential mechanisms that may explain 
the alteration in luteal function found after GnRH injection. One possibility is 
that cellular components responsible for progesterone production by normal LH 
stimulation are functionally altered. This could explain why progesterone 
production was reduced in GnRH-exposed luteal tissue in response to both LH 
and cAMP (Fig. 1). If this is true, then this functional difference must occur at a 
point distal to the accumulation of cAMP in the luteal cell. In this experiment, 
stimulation of progesterone with cAMP was depressed in corpora lutea from 
GnRH-treated heifers compared with controls. In addition, the response of this 
tissue to LH was similar to the response to cAMP. The finding that there is no 
difference in luteal adenylyl cyclase activity between saline- and GnRH-treated 
animals (Fig. 2) further supports this premise, because adenylyl cyclase is the 
enzyme responsible for the conversion of ATP to cAMP. Thus the adenylyl 
cyclase/cAMP system was not able to overcome the GnRH-induced inhibition of 
progesterone production by corpora lutea in response to LH in vitro. 
This idea is consistent with results from Rusbridge et al. (1993) who 
performed an experiment using dissociated luteal cells from untreated heifers on 
day 7 of the cycle, or heifers injected with GnRH on day 6 followed by CL 
removal on day 13 of the estrous cycle. Their results of stimulation of the cells 
with LH and dibutyryl cAMP led them to conclude that alteration in 
steroidogenic response of GnRH-exposed corpora lutea occurs at least at a point 71 
distal to the LH receptor. There are a number of other steps in the biochemical 
pathway leading to production of progesterone by the luteal cell that could 
potentially be affected subsequent to GnRH injection early in the cycle.  These 
include the cytoplasmic enzyme protein kinase A (PICA), also known as cAMP-
dependent protein kinase; the transport and mobilization of the steroid hormone 
precursor, cholesterol, into the mitochondria; the action of cytochrome P450 side 
chain cleavage complex, the enzyme system responsible for the conversion of 
cholesterol to pregnenolone; or the enzyme activity of 30-hydroxysteroid 
dehydrogenase, which converts pregnenolone to progesterone (Leers-Sucheta 
and Stormshak, 1991). 
A second possibility is that no functional difference exists between 
corpora lutea of animals that have received an injection of GnRH and controls. 
Change in cellular composition of the corpus luteum has been proposed as the 
mechanism by which alteration of luteal function occurs. Mee et al. (1993) found 
that GnRH administered 12 h after the onset of PGF2a-induced estrus (at the 
time of artificial insemination) in repeat-breeder dairy cows increased the large 
to small luteal cell ratio in corpora lutea from these animals on day 10 after 
estrus. Saline-injected control animals had a ratio of 14% large to 86% small 
cells, while those cows that received GnRH had a ratio of 31% large to 69% small 
cells. These researchers conducted an in vitro experiment as well, and found that 
early administration of GnRH did not affect basal progesterone production by 
day 10 luteal tissue slices but reduced LH-stimulated progesterone production. 
These data are similar to those in Exp. 1 of our study. In vivo experiments from 
Mee et al. (1993) indicated that serum concentrations of progesterone tended to 
be greater in both pregnant and nonpregnant GnRH-injected animals compared 
with similar saline controls. This is somewhat surprising, because in an earlier 
report (Lucy and Stevenson, 1986), the same laboratory reported a decrease in 72 
serum concentrations of progesterone in response to early GnRH administration 
under similar experimental conditions. Both studies reported an increase in 
pregnancy rates in the GnRH-injected animals compared with saline-injected 
controls. Lucy and Stevenson (1986) explained that although serum 
progesterone was lower in GnRH-treated cows, a slower rise in progesterone 
may have aided in embryo survival.  Mee et al. (1993) reported an earlier rise in 
progesterone in GnRH-treated animals, and stated that pregnancy rates were 
better in animals that had received an injection of GnRH because of greater 
serum concentrations of progesterone (due to high basal progesterone 
production from the CL). They attributed the latter to the increased number of 
large luteal cells. Large luteal cells contain few LH receptors and produce high 
basal amounts of progesterone, while small luteal cells have many LH receptors 
and produce increased quantities of progesterone in response to LH (Ursely and 
Leymarie, 1979; Koos and Hansel, 1981; Fitz et al., 1982). 
Their findings, however, cannot rule out the possibility of further 
differences in function of the luteal cells between saline- and GnRH-treated 
animals. It seems likely that if an increased large luteal cell to small luteal cell 
ratio is the only explanation for the findings by Mee et al. (1993) and the results 
of Exp. 1, then significantly higher basal progesterone production by GnRH-
exposed corpora lutea should occur, rather than just a reduction in LH (and 
cAMP)-stimulated progesterone production. However, this was not the case in 
either study. Thus it was anticipated that results of Exp. 2 would further define 
differences present in large and(or) small luteal cells from GnRH-exposed 
animals. 
Results from Exp. 2 indicate that, in the cell culture system utilized, both 
isolated small luteal cells and mixed luteal cells were able to produce the same 
quantity of progesterone basally and in response to stimulation by LH and 73 
cAMP whether they were derived from saline or GnRH-treated animals (Figs. 
3A and 3B). These data suggest that no functional difference exists between 
luteal cells of GnRH- or saline-injected animals, and that a difference in 
proportion of large luteal cells and small luteal cells may indeed account for 
alterations in luteal hormone production. The similarity in percentages of large 
luteal cells found in mixed luteal cell cultures between saline and GnRH-treated 
animals may be explained by the fragility of the large luteal cells of the bovine 
during the dissociation procedure. It is known that selective losses of large 
luteal cells occur during cell dispersion and purification procedures (Ursely and 
Leymarie, 1979; Chegini et al., 1984; Hansel et al., 1987; O'Shea et al., 1989; Lei et 
al., 1991). It is possible that, if GnRH-exposed corpora lutea had an increased 
number of large luteal cells, that these could be even more delicate than those 
normally found, such as those of control corpora lutea.  Thus a selective loss of 
large luteal cells between the two treatments might have normalized the large 
cell numbers found in the mixed cell cultures of the GnRH- and saline-exposed 
corpora lutea. 
Other factors could also provide explanation for the results found. For 
example, the potential importance of contact-dependent intercellular 
communication cannot be discounted as a reason for the different results found 
in Exps. 1 and 2. It is known that gap junctions, junctions of communication or 
electrical coupling, exist in the corpus luteum of a number of species including 
mice, rat, rabbit, dog, monkey and human (Enders, 1973; Abel et al., 1975a, 
1975b; Albertdni and Anderson, 1975; Gulyas et al., 1976; Crisp and Dessouky, 
1980). The existence of junctional structures among contacting ovine luteal cells 
has also been reported (McClellan et al., 1975; O'Shea et al., 1979).  Redmer et al. 
(1991) found that mid-cycle bovine luteal cells preincubated for 24 to 48 h then 
cultured for 16 to 24 h with LH, PGF2a or forskolin (a compound that directly 74 
activates adenylyl cyclase) had significantly higher rates of large to small cell 
communication than those incubated with no hormone. Additionally, forskolin 
increased communication between small cells. Thus, bovine luteal cells are 
capable of intercellular communication and the rate of communication can be 
influenced by hormones, implying a potential role for contact-dependent 
communication in regulation of luteal function. In the present study, tissue used 
in Exp. 1 would certainly maintain any gap junctions that would normally exist 
between luteal cells. In Exp. 2 these junctions would generally be disrupted 
during the dissociation process but could be reestablished during cell culture. 
However, the cells in Exp. 2 were maintained in culture for a shorter period of 
time than those in the study by Redmer et al. (1991). For example, in Exp. 2 an 
overnight preincubation step (approximately 16 to 18 h) occurred before 
measurement of hormone production, rather than 24 to 48 h, as in the study by 
Redmer et al. (1991). This additional time may be important for establishment of 
cell-to-cell contacts. Also, as stated above, communication between cells was 
greater in those cultures exposed to hormones for the 16 to 24 h period. Thus it 
appears that hormonal stimulation is important for formation of cellular 
contacts. In Exp. 2, cells were incubated with hormone for 2 h, a period of time 
that certainly allows stimulation of progesterone production by the cells but 
which may not be long enough to allow for the promotion of intercellular 
contacts. 
The contribution of other cell types may also be important. Endothelial 
cells, which are present in large numbers in the highly vascularized corpus 
luteum, have recently been shown to interact with luteal cells (Girsh et a1.,1995). 
According to the description of large, small and endothelial cell cultures by 
Girsh et al. (1995), it is likely that the cell cultures in Exp. 2 did contain 
endothelial cells. Endothelial cells were certainly present in the intact luteal 75 
slices from Exp. 1. Again, cell-to-cell contact may be important, as it seems that 
endothelial cells can form contacts with both small and large luteal-like cells in 
culture and this could be one way by which these vascular cells affect luteal 
function. However, they are also known to secrete PGI2, and this may be in 
important mediator in regulating luteal function. 
In summary, early administration of GnRH inhibited LH and cAMP-
stimulated progesterone production from day 7 bovine luteal slices but not from 
day 7 luteal cells after overnight cell culture. The results may be explained in a 
manner consistent with the hypothesis that an increased large luteal cell to small 
luteal cell ratio exists after GnRH injection, and that any effects of GnRH 
treatment can be attributed to this phenomenon. Still, it is difficult to explain, if 
an increased large luteal cell to small luteal cell ratio is the sole cause of altered 
luteal function in response to GnRH administration, why basal progesterone 
production by luteal slices did not increase (Exp. 1 and Mee et al., 1993). The 
possibility of functional differences in cells (luteal or nonluteal) of intact corpora 
lutea cannot be fully excluded. 76 
LUTEOLYTIC RESPONSES OF THE BOVINE CORPUS LUTEUM  
AFTER EXPOSURE TO EXOGENOUS GONADOTROPIN-
RELEASING HORMONE  
INTRODUCTION 
Few studies have examined responses of the corpus luteum to injection of 
PGF2a after previous administration of GnRH. Injection of GnRH analogue into 
heifers and cows, followed by PGF2a 6 or 7 days later, improved precision of 
estrous synchronization (Thatcher et al., 1989b; Twagiramungu et al., 1992) and 
allowed for increased pregnancy rates (Twagiramungu et al., 1992). This 
injection regimen was proposed as an alternate method of estrous 
synchronization that allowed for decreased estrous detection.  Macmillan et al. 
(1985) reported that administration of GnRH at various times during diestrus, 
followed by injection of PGF2a 15 min, 24 h or 72 h later did not affect decline in 
plasma progesterone caused by PGF2a but did seem to inhibit structural demise 
of the CL. However, studies specifically examining the effect of GnRH injection 
early in the estrous cycle on PGF2a-induced luteal regression in mid-cycle have 
not been conducted. 
Oxytocin is a hormone produced by large luteal cells , stored in secretory 
granules and secreted by exocytosis through the activation of PKC (reviewed by 
Stormshak et al., 1995). Release of oxytocin, through a protein kinase C-
dependent mechanism in response to PGF2a, is an indicator that the CL is 
undergoing luteolysis. Because there is thought to be an increased large luteal 
cell to small luteal cell ratio in corpora lutea exposed early in the estrous cycle to 
GnRH (Mee et al., 1993), it is possible that GnRH-exposed corpora lutea would 
respond to the luteolytic stimulus PGF2a with an increased secretion of oxytocin. 77 
Davis et al. (1995) have shown that PGF2a-stimulated PKC activates the MAP 
kinase cascade in causing the release of TGFO from bovine luteal cells. They 
hypothesized that this cascade causes phosphorylation of transcription factors in 
the luteal cell, presumably including c-jun (Khan et al., 1993, 1994). Activated 
transcription factors can then bind regulatory sites such as the AP-1 site on genes 
such as TGFI3 to up-regulate expression and subsequent secretion. Thus, it is 
possible that other PGF2a-mediated exocytotic events from luteal cells can occur 
in a similar manner. Additionally, it has been suggested that the early response 
gene c-jun and its product may play a role in luteolysis (Khan 1993, 1994). 
Therefore the objective of the present study was to determine if the PGF2a-
induced up-regulation of c-jun message in the bovine CL could be altered by 
early administration of GnRH. A corollary objective was to determine if GnRH 
administration can alter PGF2-induced oxytocin secretion on day 8 of the 
estrous cycle. 
MATERIALS AND METHODS 
Experimental Design 
The present experiment was conducted to determine whether exogenous 
GnRH can alter responses of the corpus luteum to exogenous prostaglandin Fla 
(PGF2a). A preliminary experiment was first performed to determine if PGF2a 
can alter c-jun expression in the bovine corpus luteum as has been described for 
the rat (Khan et al., 1993, 1994). Two beef heifers were injected with 500 lig 
cloprostenol, a PGF2a analogue, (Estrumate, Mobay Corp., Shawnee, KS) i.v. on 
day 8 of the estrous cycle; one heifer received an injection of saline. Corpora 78 
lutea were removed 60 min after injection, frozen in liquid nitrogen and stored 
at -80°C until RNA analysis. An additional day 8 corpus luteum from a heifer 
that did not receive an injection also served as a control. 
For the actual experiment, beef heifers were injected with saline or GnRH 
on day 2 of the estrous cycle (n = 4 animals per group). On day 8 of the cycle, 
animals were restrained and the jugular vein catheterized with a 16-gauge, 8.3 
cm Angiocath® catheter (Deseret Medical Inc., Becton Dickinson and Co., Sandy, 
UT). Clotting in the catheter was prevented by infusion of a 3.5% sodium 
citrate-0.2% oxytetracycline solution. Blood samples were then collected with 
Vacutainer tubes (Becton Dickinson and Co., Rutherford, NJ) for determination 
of serum progesterone or plasma oxytocin (collected in heparinized Vacutainers) 
and designated "time zero" samples. Ten microliters of 5 mg/ml 1,10-
phenanthroline (Sigma) and 20 41 of 0.5 M EDTA were added immediately to 
this and all subsequent oxytocin samples to prevent oxytocinase activity 
(Kumarasen et al., 1974). All blood samples were placed on ice after collection. 
Next 500 lig cloprostenol (PGF2a)was injected via the catheter (time zero). Blood 
samples for oxytocin were collected as above at 1.5, 3, 6, 9, 12, 15, 20, 25, 30 and 
35 min after PGF2a injection. Caudal epidural anesthesia was then induced with 
2% lidocaine hydrochloride and a vaginal incision was made for removal of the 
corpus luteum. At 60 min after injection, a blood sample was taken for 
determination of progesterone and the CL was removed and frozen in liquid 
nitrogen. Corpora lutea were stored at -80°C until analysis for c-jun expression 
and tissue concentrations of oxytocin. Blood samples were centrifuged for 10 to 
15 min at 2540 x g at 4°C. Serum samples were allowed to clot at 4°C overnight 
before centrifugation. Both plasma and serum were stored at -20°C until 
hormone radioimmunoassay. 79 
Oxytocin Radioimmunoassay 
Oxytocin in plasma samples was extracted and assayed as recently 
described by Orwig et al. (1994) by methods adapted from Abdelgadir et al. 
(1987) and Schams (1983). Oxytocin was extracted from tissue samples by the 
method of Tsang et al. (1990) before analysis. For the plasma extraction, a 
Waters vacuum manifold was utilized with Sep-Pak® Plus C-18 cartridges 
(Waters Chromatography Division, Millipore Corp., Milford, MA). Mean 
extraction efficiency for plasma was 75.0±0.7% and for tissue 93.6±1.6%. 
Oxytocin antibody was generously provided by Dr. Dieter Schams, Technical 
University of Munich, Freising-Weihenstephan, Germany. Intra- and interassay 
coefficients of variation were 9.6±0.7% and 3.4%, respectively. 
Progesterone Radioimmunoassay 
Progesterone in duplicate serum samples (100 IA each) was extracted with 
2 ml benzene:hexane (1:2) by vortexing for 30 sec. Samples were placed at -20°C 
overnight and the next day the organic phase was decanted into new tubes, 
dried down and used in the assay. A third tube for each sample containing 100 
ul serum plus 4800 cpm [3H]progesterone was extracted for determination of 
extraction efficiency. Mean extraction efficiency, used for all samples, was 
85.5%. Radioimmunoassay was performed using progesterone standards (5 
pg/tube to 800 pg/tube), anti-progesterone-11-BSA (Dr. Gordon Niswender, 
Colorado State University, Fort Collins, CO) and 20,000 cpm/tube of 
[3H]progesterone (Dupont NEN). Bound and free fractions were separated 80 
using dextran-coated charcoal. The intrassay coefficient of variation was 7.34% 
(n = 1 assay). 
RNA Extraction and Northern Blotting 
For extraction of RNA, luteal tissue (approximately 300 mg) was 
pulverized with a mortar and pestle under liquid nitrogen then placed in 10 
volumes (3 ml) TRIzol® reagent (Gibco), a monophasic solution of phenol and 
guanidine isothiocyanate (Chomczynski, 1993). Extraction was performed 
according to the manufacturer's protocol, which included addition of 
chloroform, an isopropanol precipitation and centrifugation steps. Recovered 
RNA was dissolved in 50 p.1 diethylpyrocarbonate (DEPC) treated water. 
Quantity and purity of RNA was determined spectrophotometrically. 
To denature the RNA, samples were heated to 55°C for 15 min with 
sample-preparation buffer in a ratio of 9:31. Sample-preparation buffer 
consisted of 1 part 10X MOPS buffer (0.2 M MOPS, 80 mM sodium acetate, pH 
7.0), 1.75 parts deionized formaldehyde and 5 parts deionized formamide. 
Denatured samples plus 2 pl gel-loading buffer (50% glycerol, 0.25% 
bromophenol blue, 0.25% xylene cyanol FF) were loaded onto a formaldehyde 
agarose gel (1%) containing approximately 0.8 µg /ml ethidium bromide. 
Electrophoresis was performed overnight at 30 V in lx MOPS buffer. 
After electrophoresis, the gel was rinsed for 1 h in DEPC-treated water, 
RNA bands were visualized under UV light and photographed. The gel was 
then soaked in 6X SSC buffer for 10 to 15 min (1X SSC = 0.15 M sodium chloride, 
15 mM sodium citrate, pH 7.0). RNA was transferred onto a Nytran Plus nylon 
membrane (Schleicher & Schuell, Keene, NH) by capillary transfer. After 48 h, 81 
the membrane was rinsed briefly with 5X SSC then UV cross-linked at 120,000 
14/cm2. 
The membrane was prehybridized at 42°C for at least 6 h with 200 til/cm2 
prehybridization solution [50% deionized formamide, 5X SSC, 50 mM K2PO4 pH 
8.0, 5X Denhart's solution (0.1% each BSA, Ficoll and polyvinylpyrrolidone; 
Sigma), 100 µg/ ml salmon testes DNA for hybridization (Sigma) and 0.1% SDS] 
in a rotating hybridization oven (Robbins Scientific, Sunnyvale, CA). The 
membrane was then hybridized with the appropriate labeled cDNA probe. The 
probe for c-jun was made from a plasmid insert of the full-length mouse c-jun 
cDNA obtained from Dr. Rodrigo Bravo, Bristol-Myers Squibb Pharmaceutical 
Research Institute, Princeton, NJ. Probes made from this template have been 
successfully used to examine c-jun expression in bovine tissue (Clark et al., 
1992). The probe for 18S ribosomal RNA was made from a plasmid insert 
containing 80 by of the human 18S rRNA gene (Ambion, Austin, TX). This 
sequence is highly conserved and can be used as a template to make an 18S 
probe that will bind to this rRNA from all vertebrates with few, if any, 
mismatches. Probes were made using the appropriate cDNA template by 
random hexanucleotide priming with [3211d= (Dupont NEN) as the 
radioactive label (Prime-a-Gene® Labelling System, Promega, Madison, WI). 
Unincorporated label was removed by passage though a Sephadex® G-50 
column (Quick SpinTM columns, Boehringer Mannheim, Indianapolis, IN). 
Labeled probe was added to the hybridization solution to obtain 
approximately 1.5 to 3 x 106 cpm/ml. Hybridization solution (50 p.1/cm2 
membrane) contained 50% deionized formamide, 5X SSC, 20 mM K2PO4 pH 6.5, 
1X Denhart's solution, 100 pg/m1 salmon testes DNA for hybridization and 0.1% 
SDS. After the overnight hybridization (approximately 16 h) at 42°C, 
membranes were washed in 2X SSC, 0.1% SDS for 30 mM at room temperature. 82 
Blots were then placed in plastic wrap and exposed to a storage phosphor screen 
(Molecular Dynamics, Sunnyvale, CA) for approximately 4 h. Screens were 
scanned by a phosphorimager and visualized with ImageQuaNTTm software 
(Molecular Dynamics). If further washing was necessary to remove nonspecific 
signal, membranes were washed for 15 min twice with 2X SSC, 0.1% SDS at 50° 
C. Some were washed further with 0.1X SSC, 0.1% SDS at 50°C for 30 min. 
Membranes were then exposed to the phosphor screen overnight or for several 
days. Between probing for c-jun and 18S mRNA, membranes were stripped 
with 50% formamide, 6X SSPE (1X SSPE = 0.18 M NaC1, 10 mM sodium 
phosphate, 1 mM EDTA, pH 7.4) for 30 to 45 min at 65°C. 
Signal densities were quantitated with ImageQuaNT using volume 
quantitation of equal areas for any given signal. Background correction was 
computed by the local average method. Intensity of the c-jun signal relative to 
the 18S signal was calculated, to assure that comparisons were made between 
equal quantities of RNA. 
Statistical Analysis 
Difference in ratio of luteal c-jun/18S RNA for saline or GnRH-treated 
heifers was determined by student's t-test with Statgraphics (STSC, Rockville, 
MD). Differences in both plasma oxytocin and serum progesterone were 
analyzed by repeated measures ANOVA using the general linear model of SAS 
(1993). Treatment (saline or GnRH), animal(treatment), time and treatment x 
time were used as the sources of variation. Treatment was tested for significance 
using animal(treatment) as the error term. Differences among mean plasma 
concentrations of oxytocin at sampling times after PGF2ct injection were 83 
determined by Least Significant Difference test. Differences among mean serum 
concentrations of progesterone were determined by the contrast procedure of 
SAS. Differences in peak oxytocin concentrations between treatments, as well as 
tissue oxytocin concentrations were determined by t-test using Statgraphics. 
Statistical consultation was provided by Dr. David Thomas, Dept. of Statistics, 
Oregon State University. 
RESULTS 
Administration of PGF2c, to beef heifers on day 8 of the estrous cycle 
increased luteal expression of c-jun at 60 min after injection when compared 
with control animals (Fig. 4). A major transcript was found at 2.7 kb, and a 
minor transcript was found at approximately 3.6 kb. When the amount of major 
transcript was quantitated and expressed relative to signal intensity for 18S, 
treated animals showed a 10- to 20-fold higher induction of c-jun than control 
animals (Fig. 5). However, GnRH administration on day 2 was not able to alter 
this PGF2a-induced c-jun expression at 60 min after injection, either positively or 
negatively (Fig. 6) when normalized to signal for 18S rRNA (Fig. 7). Plasma 
oxytocin increased significantly after PGF2e, injection, but there were no 
differences between saline and GnRH-treated animals (Fig. 8). The mean 30 and 
35 min plasma oxytocin samples were not significantly different from the time 0 
sample (p>0.05), indicating that the oxytocin levels had returned to baseline by 
30 min after PGF2o, injection. Sample means at all other times were significantly 
different from the time 0 mean (p<0.01). Analysis of peak plasma concentrations 
of oxytocin (pg/ml) for individual animals in the saline vs. GnRH treatments 
revealed no difference between injections (saline, 129.1±36.5; GnRH, 124.5±23.5; 84 
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Figure 4. Northern blot of c-jun mRNA from day 8 bovine corpora lutea. Lanes 
1 and 2:  animals received an injection of 500 lig cloprostenol (PGF2a) 60 min 
prior to removal of corpus luteum. Lane 3: animal received no injection. Lane 
4: animal received injection of saline 60 min prior to removal of corpus luteum. 
18S rRNA was probed to determine equality of loading. 85 
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Figure 5. Density of c-jun mRNA signal normalized to the 18S signal for each 
lane of Fig. 4. Quantitation was performed using volume quantitation of equal 
areas for a specific signal. Background was corrected for by subtraction of the 
local average around the area quantitated. The legend below the graph indicates 
treatment received by individual beef heifers 60 min prior to corpus luteum 
removal. 86 
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Figure 6. Northern blot of c-jun mRNA from day 8 bovine corpora lutea 60 min 
after injection of PGF2a. Animals had received an injection of saline (lanes 1-4) or 
GnRH (lanes 5-8) on day 2 of the estrous cycle.  18S rRNA was probed to 
determine equality of loading. 87 
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IN VIVO TREATMENT 
Figure 7.  Mean (±SE) densities of c-jun mRNA signal normalized to the 18S 
signal for Fig .  6. "Saline" represents corpora lutea from animals receiving saline 
injection on day 2 of the cycle (lanes 1  - 4) and "GnRH" those receiving GnRH 
injection on day 2 (lanes 5 - 8).  All animals received an injection of PGF2a 60 
min prior to corpus luteum removal. There was no alteration in the PGF2a 
induced c-jun expression by early administration of GnRH. 88 
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Figure 8. Plasma oxytocin concentrations in beef heifers on day 8 of the estrous 
cycle following PGF2c, injection at time 0.  "Saline" and "GnRH" indicate 
treatments administered on day 2 of the estrous cycle (n = 4 animals/group). 89 
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Figure 9.  Serum concentrations of progesterone at 0 and 60 min after PGF2c, 
injection into beef heifers on day 8 of the estrous cycle. Gray bars indicate those 
animals that had received saline injection on day 2, black bars those that 
received GnRH injection. There was no effect of GnRH injection, however, PGF2 
a injection significantly decreased progesterone concentrations in both saline and 
GnRH-treated animals by 60 min after injection (p<0.05). 90 
p>0.05; data not shown). Peak oxytocin concentrations for all animals occurred 
between 3 and 12 min after PGF2o, injection. Oxytocin in luteal tissue (ng/g 
tissue) removed 60 min after PGF20, also did not change due to GnRH treatment 
(saline, 24.07±8.6; GnRH, 19.31±6.0; p>0.05; data not shown). Serum 
concentrations of progesterone (ng/ml) significantly declined by 60 min after 
PGFav compared to the zero time sample in both groups (saline 0 min 3.73±0.79, 
60 min 2.69±1.1; GnRH 0 min 2.98±0.38, 60 min 1.87±0.38; p<0.05; Fig. 9) but 
GnRH injection did not alter progesterone concentrations (p>0.05). However, 
there was a trend for serum concentrations of progesterone to be lower in GnRH-
treated than in control heifers. 
DISCUSSION 
The potential relevance of the newly discovered mitogen-activated 
protein kinase cascade as well as its induction and activation of transcription 
factors such as c-jun have been examined only recently in domestic animals. The 
induction of c-jun in the CL by PGF2,x found in this experiment seems to be the 
first report of this phenomenon with the exception of the rat (Khan et al., 1993, 
1994). The size of the transcripts is consistent with those reported for other 
steroidogenic tissues. In the rat corpus luteum, a major transcript at 2.6 kb and a 
minor transcript at 3.5 kb have been found (Khan et al., 1993). In bovine adrenal 
tissue, the major transcript is found at 2.7 kb and a minor transcript at 3.4 kb (Dr. 
Mirjana Cesnajaj, National Institutes of Health, Bethesda, MD, personal 
communication). Additionally, mouse Y1 adrenocortical cells show transcripts 
for c-jun at 2.7 and 3.6 kb (Kimura et al., 1993). The present study has shown 
message for c-jun at 2.7 (major transcript) and 3.6 kb (minor transcript) in the 
bovine corpus luteum (Fig. 4). 91 
The induction of c-jun mRNA 60 min after in vivo PGF2a injection also 
agrees with the published reports of Khan et al. (1993, 1994). Thirty minutes 
after a second injection of PGF2a, c-jun was up-regulated in both day 7 rat 
corpus luteum and extraluteal tissues (Khan et al., 1993). A time course 
experiment revealed that c-jun message increased by 15 min after injection of 
PGF2ov and remained high at 30 min and until at least 2 h post-injection. A 
fourfold induction of c-jun by PGF2a was also reported (Khan et a1.,1994). In 
the present study a 10- to 20-fold induction of c-jun was found in CL removed 60 
min after PGF2a injection compared to controls (Fig. 5). The reason for the 
difference in the amount of c-jun induction in the present study and that of Khan 
et al. (1994) cannot be fully ascertained. One possible explanation is that Khan et 
al. (1994) examined time points of 15, 30 and 120 min after injection of PGF2a 
while the present study utilized CL removed 60 min after injection. It is possible 
that a "peak" of c-jun induction occurred sometime between 30 and 120 min post-
injection and thus time point differences were not observed in the study by Khan 
et al. (1994), yet the present study may have examined induction of c-jun closer 
to its "peak". A time course experiment utilizing several additional time points 
post-injection would be necessary to substantiate this idea. Potential differences 
between species cannot be ignored, however, nor can small differences in 
detection techniques that may disallow direct comparison between experiments. 
Preliminary reports have indicated that the MAP kinase cascade is indeed 
active in corpora lutea of domestic animals (Davis et al., 1995; Hildebrandt et al., 
1995), and that protein kinase C activates this pathway in these species (Davis et 
a1.,1995). Because this cascade is known to activate the early response genes c-
fos and c-jun, and PGF20, is known to act through activation of PKC in the CL, 
our finding fits into this larger picture of luteal cell function. Khan et al. (1993, 
1994) proposed that the induction of c-jun may be an event necessary for 92 
luteolysis, as it certainly is up-regulated during PGF2a-induced luteal 
regression. Thus, in the present study, we utilized this induction of c-jun 
expression as an indicator to examine whether early administration of GnRH 
could alter the response of the corpus luteum to a luteolytic stimulus. 
Early administration of GnRH, however, did not alter PGF2a-induced expression 
of c-jun in the bovine CL in this experiment (Figs. 6 and 7). There are several 
possible explanations for this occurrence. One is simply that any effect 
exogenous GnRH may have on the CL did not affect those pathways that involve 
expression of this early response gene in luteal cells. Additionally, expression of 
c-jun at the time point after PGF2a injection (60 min post-injection) may not have 
been altered, but it is possible that the rise in c-jun message or its decline to 
baseline quantities was. Because the study was not a time course experiment, 
changes in the rate of c-jun induction, rather than in the amount of induction 
alone, cannot be ascertained at the present time. It is also possible that c-jun is 
differentially up- or down-regulated in large or small luteal cells, a process that 
could be affected by GnRH, but not found in whole CL extract. 
Early administration of GnRH is thought to increase the large luteal cell to 
small luteal cell ratio in the bovine CL (Mee et al., 1993). Because oxytocin, a 
hormone important in luteal regression, is derived from the large cells of the CL, 
it is possible that administration of GnRH could alter oxytocin secretionfrom the 
CL. In addition, the release of oxytocin from the bovine CL after injection of 
PGF2a can be used as another indicator of luteolytic potential of GnRH-exposed 
corpora lutea. In the present study, however, neither concentrations of plasma 
oxytocin (Fig. 8) nor oxytocin in luteal tissue 60 min after injection of PGF2a 
were significantly altered by early administration of GnRH. In contrast, 
Whitmore (1995) showed a reduction in naturally-secreted luteal oxytocin on 
days 12 and 14 in intact ewes that had been injected with GnRH on days 2 and 3 93 
of the cycle. However, other studies that have examined the luteolytic potential 
of the CL after exogenous GnRH, LH or hCG have only examined whether these 
compounds can affect the decline in progesterone production by the CL. In the 
present study, serum concentrations of progesterone did fall by 60 min after 
injection of PGF2a, but at neither 0 nor 60 min after PGF2a were the serum 
concentrations of progesterone significantly affected by early administration of 
GnRH (Fig. 9). Bolt (1979) found that attempts to alter the luteolytic effect of 
PGF2a treatment on day 10 with hCG administered early in the estrous cycle to 
ewes were variable and for the most part unsuccessful. But when hCG was 
given on days 9 to 10, PGF2a injection on day 10 was unable to induce luteal 
regression in ewes. This finding, however, contrasts with those of several others. 
In cows, Litch and Condon (1988) followed a similar protocol but found that 
hCG did not alter PGF2a-induced regression of the CL, and that in vitro 
progesterone production was decreased in hCG/PGF2a-treated animals 
compared to non-injected controls. In mid-cycle cows (Gonzalez-Mencio et al., 
1977) and ewes (Sasser et al., 1977) infusion of LH for 10 or 12 h did not affect 
PGF2a-induced luteal regression when PGF2a was injected during the infusion. 
In both studies, decline in serum progesterone was similar in control and treated 
animals. Interestingly, Macmillan et al. (1985) found that injection of the GnRH 
agonist Buserelin at various times during diestrus, 15 min, 24 h or 72 h before 
injection of PGF2a did not alter functional luteolysis, but prevented or slowed 
structural luteolysis. Plasma concentrations of progesterone declined similarly 
in GnRH-pretreated and control animals after injection of PGF2a. In animals 
injected with PGF2a alone, however, palpated CL were detectably smaller by 24 
h post-injection, while those also treated with GnRH did not change in size until 
at least 3 days after PGF2a injection. In the present study, serum concentrations 
of progesterone also declined in both control and GnRH-treated animals after 94 
PGF2a injection. However, alteration of structural changes could not be assessed 
because the CL were removed 60 min after injection of PGF2a. 
To summarize, both c-jun gene expression and plasma concentrations of 
oxytocin increased following injection of PGF20, into beef heifers on day 8 of the 
estrous cycle, while serum concentrations of progesterone declined. These are 
expected responses of the corpus luteum when exposed to a luteolytic dose of 
PGF2a. However, injection of GnRH on day 2 of the cycle was unable to alter 
these PGF2a-induced events. Alteration of luteal function after early 
administration of GnRH does not appear to involve PGF2a-responsive cellular 
mechanisms. 95 
GENERAL CONCLUSIONS  
The present study has examined the effect of exogenous GnRH on the 
corpus luteum at various stages of the luteal life span.  Injection of GnRH on day 
2 of the estrous cycle allows for modification of the hormonal milieu of the 
corpus luteum during its development Examination of the responses of luteal 
slices or cells to hormonal stimuli on day 7 demonstrated how early injection of 
this decapeptide can alter luteal performance as it nears the time of full 
functionality. Oxytocin secretion in response to PGF2,1 is greatest on day 8, and 
thus the beginning of the luteolytic process could also be explored. 
The role of GnRH in alteration of progesterone production by the CL still 
seems to be somewhat enigmatic. In the first experiment, GnRH was able to 
inhibit both LH and cAMP-stimulated progesterone production by bovine luteal 
slices. However, when a cell culture system was used in Exp. 2, no effect of 
GnRH was found. Mee et al. (1993) explained inhibition of hormone-stimulated 
progesterone production from luteal slices by showing an increased large luteal 
cell to small luteal cell ratio in GnRH-exposed corpora lutea. Thus, the presence 
of more large cells and fewer small cells does not allow for the same amount of 
stimulation as in control CL, because the small cells are the ones considered to be 
responsive to LH. However, in neither the present study nor that of Mee et al. 
(1993) is the lack of change in basal progesterone production by the luteal slices 
easily explained. Because large cells produce more progesterone in the absence 
of hormonal stimuli, it should be expected that the basal progesterone 
production would actually increase at the same time the hormone-stimulated 
progesterone decreased. This was not the case, however. Mee et al. (1993) did 
find that serum progesterone was increased after early administration of GnRH, 96 
and stated that this finding supported their cell-size hypothesis, because the 
main source of progesterone in vivo can be considered to be basal progesterone 
from the large cells. However, in the present studies no change in serum 
concentrations of progesterone was found on days 7 or 8 after injection of GnRH 
on day 2 of the cycle. Various studies have found no change, increases or 
decreases in serum progesterone after injection of GnRH. Thus the effect of 
GnRH on the corpus luteum is somewhat variable, and while the data presented 
herein are consistent with the hypothesis of Mee et al. (1993), other factors 
influencing progesterone production by the CL after GnRH injection cannot be 
fully excluded. These can include changes in intracellular functioning at a point 
distal to the accumulation of cAMP in the luteal cell. 
In considering other hormones, it does not appear that GnRH alters 
PGF20,-induced oxytocin secretion nor the decline in serum progesterone 
indicative of ebbing luteal function. Thus one practical application of this 
research might be that in the event of a misdiagnosis of follicular cysts. Use of 
GnRH is not detrimental even in the absence of follicular cysts, because if the 
animal does not return to estrus as expected PGF2c, can subsequently be 
administered. The GnRH-exposed corpus luteum will behave normally in 
response to this luteolytic stimuli. The use of GnRH and PGF20, has already been 
suggested as an estrous synchronization tool that allows for more precise timing 
of synchronization (Thatcher et al., 1989b; Twagiramungu et al., 1992). Thus it 
actually seems an advantage that GnRH does not alter PGF2ccinduced luteal 
regression. 
One avenue of research that is currently unexplored is the study of gene 
regulation in the corpus luteum after GnRH injection early in the estrous cycle. 
It would be of interest to know what genes are up- or down-regulated by early 
GnRH administration so that the cellular mechanisms by which GnRH acts, 97 
rather than mechanisms in place after it has already had its effect, can be 
ascertained. A technique such as differential display PCR could possibly be 
utilized, comparing genes unique to early corpora lutea of controls relative to 
those of CL exposed to GnRH. Recently this technique has been used 
successfully to examine genes unique to ovulation (Espey et al., 1995) and the 
luteinization process (Leers-Sucheta and Melner, 1995). In the present report, 
regulation of the c-jun gene has been examined subsequent to PGF2a, or GnRH 
and PGF2a, injections. Luteal regression is a complex process that is certainly not 
fully understood, especially at the molecular level. Thus, further exploration of 
gene regulation during luteolysis is warranted, including both early response 
genes and delayed response genes. The present study supports the findings of 
Khan et al. (1993, 1994) in showing that expression of the early response gene c-
jun is up-regulated during PGF2a-induced luteolysis in the rat and now, the 
cow. Additionally, study of protein(s) produced by gene up-regulation after 
PGF2a, could lead to further comprehension of the luteolytic process. Perhaps 
examination of gene regulation or the activation/phosphorylation of the c-jtui 
protein itself during the course of normal luteal regression (near the end of the 
estrous cycle) could provide insight into its physiological role. 
The corpus luteum is a unique, transient endocrine organ, and it possesses 
qualities that have made it the focus of many research studies. It grows rapidly 
from the ovulated follicle, produces quantities of hormone that can sustain at 
least the beginnings of pregnancy and it regresses when it is no longer needed, 
such as at end of a non-fertile estrous cycle. Study of this tissue has provided 
numerous insights into the control of reproductive function. Many more 
investigations, especially at the level of gene regulation in the corpus luteum, 
remain to be completed. 98 
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